Mitesco (MITI) 10-Q 13 Nov 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 11, 2020
Document Information Line Items
Entity Registrant Name	MITESCO, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		136,209,054
Amendment Flag	false
Entity Central Index Key	0000802257
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	true
Entity Interactive Data Current	Yes

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 101,660	$ 83,245
Prepaid expenses	3,784	9,721
Total current assets	105,444	92,966
Fixed assets, net of accumulated depreciation of $786 and $0	6,675	7,854
Total Assets	112,119	100,820
Current liabilities
Accounts payable and accrued liabilities	501,312	648,714
Accrued interest	135,529	82,870
Derivative liabilities	1,124,852	1,488,423
Convertible notes payable, net of discount of $864,964 and $646,888	225,836	77,112
Convertible note payable, in default	122,166	122,166
SBA Loan Payable	460,406	0
Other current liabilities	94,402	0
Preferred stock dividends payable	56,143	0
Total current liabilities	2,720,646	2,419,285
Total Liabilities	2,720,646	2,419,285
Commitments and contingencies
Stockholders' (equity)
Common stock, $0.01 par value, 500,000,000 shares authorized, 121,452,914 and 81,268,443 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	1,214,529	812,684
Additional paid-in capital	9,664,232	8,407,977
Stock payable	37,186	37,186
Accumulated deficit	(13,524,784)	(11,576,574)
Total (deficiency in) stockholders' (equity)	(2,608,527)	(2,318,465)
Total liabilities and stockholders' (equity)	112,119	100,820
Series A Preferred Stock [Member]
Current liabilities
Preferred stock dividends payable	6,967
Stockholders' (equity)
Preferred stock	48	0
Series X Preferred Stock [Member]
Current liabilities
Preferred stock dividends payable	49,176
Stockholders' (equity)
Preferred stock	$ 262	$ 262

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Fixed assets, accumulated depreciation (in Dollars)	$ 786	$ 0
Convertible notes payable, discount (in Dollars)	$ 864,964	$ 646,888
Common stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	121,452,914	81,268,443
Common stock, shares outstanding	121,452,914	81,268,443
Series A Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued	4,800	0
Preferred stock, shares outstanding	4,800	0
Series X Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued	26,227	26,227
Preferred stock, shares outstanding	26,227	26,227

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
General and administrative	607,704	433,322	1,730,036	880,823
Total operating expenses	607,704	433,322	1,730,036	880,823
Net Operating Loss	(607,704)	(433,322)	(1,730,036)	(880,823)
Other income (expense):
Grant income	0	0	3,000	0
Interest expense	(537,184)	(832,417)	(1,124,219)	(1,157,318)
Gain on settlement of accounts payable	49,351	50,366	397,962	50,366
Gain on settlement of accrued salary	6,988	0	6,988	0
(Loss) Gain on derivative liabilities	51,940	(69,611)	498,095	(69,611)
Loss on legal settlement	0	0	0	(26,924)
Loss on conversion of notes	0	(2,799)	0	(161,458)
Total other expense	(428,905)	(854,461)	(218,174)	(1,364,945)
Loss before provision for income taxes	(1,036,609)	(1,287,783)	(1,948,210)	(2,245,768)
Provision for income taxes	0	0	0	0
Net loss	(1,036,609)	(1,287,783)	(1,948,210)	(2,245,768)
Preferred stock dividend	(19,392)	0	(56,143)	0
Net loss available to common shareholders	$ (1,056,001)	$ (1,287,783)	$ (2,004,353)	$ (2,245,768)
Net loss per share - basic and diluted (in Dollars per share)	$ (0.01)	$ (0.03)	$ (0.02)	$ (0.06)
Weighted average shares outstanding - basic and diluted (in Shares)	100,262,378	43,360,914	94,154,754	36,446,415

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)	Series A Preferred Stock [Member]Preferred Stock [Member]	Series A Preferred Stock [Member]	Series X Preferred Stock [Member]Common Stock [Member]	Series X Preferred Stock [Member]Additional Paid-in Capital [Member]	Series X Preferred Stock [Member]Preferred Stock [Member]	Series X Preferred Stock [Member]	Common Stock [Member]Warrant [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]Share-based Payment Arrangement, Option [Member]	Additional Paid-in Capital [Member]Warrant [Member]	Additional Paid-in Capital [Member]Discount on Note Payable Due to Warrants [Member]	Additional Paid-in Capital [Member]	Stock Payable [Member]	Retained Earnings [Member]	Share-based Payment Arrangement, Option [Member]	Warrant [Member]	Discount on Note Payable Due to Warrants [Member]	Total
Balance at Dec. 31, 2018								$ 315,982				$ 5,684,208	$ 37,186	$ (7,691,312)				$ (1,653,936)
Balance (in Shares) at Dec. 31, 2018								31,598,236
Stock issued to employees subject to vesting								$ 29,750				(17,520)						$ 12,230
Stock issued to employees subject to vesting (in Shares)								2,975,000										2,975,000
Stock issued for conversion of notes payable			$ 143,940	$ 414,230		$ 558,170
Stock issued for conversion of notes payable (in Shares)			14,394,002
Preferred stock dividends																		$ 0
Shares issued for legal settlement								$ 14,012				87,016						101,028
Shares issued for legal settlement (in Shares)								1,401,224
Discount on notes payable due to conversion feature												223,087						223,087
Vesting of shares issued to employees												124,848						124,848
Stock issued for services								$ 2,000				15,480						17,480
Stock issued for services (in Shares)								200,000
Settlement of derivative liabilities												203,730						203,730
Debt discount due to issuance of warrants											$ 34,500						$ 34,500
Cancellation of shares								$ (7,000)				7,000
Cancellation of shares (in Shares)								(700,000)
Imputed interest												6,750						6,750
Net loss for the period														(2,245,768)				(2,245,768)
Balance at Sep. 30, 2019								$ 498,684				6,783,329	37,186	(9,937,080)				(2,617,881)
Balance (in Shares) at Sep. 30, 2019								49,868,462
Balance at Dec. 31, 2018								$ 315,982				5,684,208	37,186	(7,691,312)				(1,653,936)
Balance (in Shares) at Dec. 31, 2018								31,598,236
Balance at Dec. 31, 2019	$ 0				$ 262			$ 812,684				8,407,977	37,186	(11,576,574)				$ (2,318,465)
Balance (in Shares) at Dec. 31, 2019	0				26,227			81,268,443										81,268,443
Balance at Jun. 30, 2019								$ 390,774				6,370,513	37,186	(8,649,297)				$ (1,850,824)
Balance (in Shares) at Jun. 30, 2019								39,077,529
Stock issued to employees subject to vesting								$ 19,750				(7,520)						12,230
Stock issued to employees subject to vesting (in Shares)								1,975,000
Stock issued for conversion of notes payable								$ 91,160				111,601						202,761
Stock issued for conversion of notes payable (in Shares)								9,115,933
Preferred stock dividends																		0
Vesting of shares issued to employees												104,465						104,465
Settlement of derivative liabilities												203,730						203,730
Cancellation of shares								$ (3,000)				3,000
Cancellation of shares (in Shares)								(300,000)
Imputed interest												2,250						2,250
Net loss for the period														(1,287,783)				(1,287,783)
Balance at Sep. 30, 2019								$ 498,684				6,783,329	37,186	(9,937,080)				(2,617,881)
Balance (in Shares) at Sep. 30, 2019								49,868,462
Balance at Dec. 31, 2019	$ 0				$ 262			$ 812,684				8,407,977	37,186	(11,576,574)				$ (2,318,465)
Balance (in Shares) at Dec. 31, 2019	0				26,227			81,268,443										81,268,443
Stock issued for conversion of notes payable								$ 315,976				508,066						$ 824,042
Stock issued for conversion of notes payable (in Shares)								31,597,490
Issuance of Preferred A stock to consultants	$ 48											71,510						71,558
Issuance of Preferred A stock to consultants (in Shares)	4,800	4,800
Preferred stock dividends		$ (6,967)				$ (49,176)						(56,143)						(56,143)
Shares issued for legal settlement																		0
Discount on notes payable due to conversion feature																		0
Vesting of shares issued to employees												60,842						60,842
Vesting of stock options issued to employees									$ 119,227						$ 119,227
Stock issued for services								$ 5,869				23,467						29,336
Stock issued for services (in Shares)								586,985
Settlement of derivative liabilities												528,995						528,995
Common stock issued in warrant settlement agreement							$ 80,000			$ 291						$ 80,291
Common stock issued in warrant settlement agreement (in Shares)							7,999,996
Imputed interest																		0
Net loss for the period														(1,948,210)				(1,948,210)
Balance at Sep. 30, 2020	$ 48				$ 262			$ 1,214,529				9,664,232	37,186	(13,524,784)				$ (2,608,527)
Balance (in Shares) at Sep. 30, 2020	4,800				26,227			121,452,914										121,452,914
Balance at Jun. 30, 2020	$ 48				$ 262			$ 987,962				9,058,332	37,186	(12,488,175)				$ (2,404,385)
Balance (in Shares) at Jun. 30, 2020	4,800				26,227			98,796,144
Stock issued for conversion of notes payable								$ 222,698				508,066						730,764
Stock issued for conversion of notes payable (in Shares)								22,269,785
Preferred stock dividends												(19,392)						(19,392)
Vesting of shares issued to employees												7,792						7,792
Vesting of stock options issued to employees												91,647						91,647
Stock issued for services								$ 3,869				17,787						21,656
Stock issued for services (in Shares)								386,985
Net loss for the period														(1,036,609)				(1,036,609)
Balance at Sep. 30, 2020	$ 48				$ 262			$ 1,214,529				$ 9,664,232	$ 37,186	$ (13,524,784)				$ (2,608,527)
Balance (in Shares) at Sep. 30, 2020	4,800				26,227			121,452,914										121,452,914

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,948,210)	$ (2,245,768)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	1,179	0
Loss on conversion of liabilities to preferred stock	0	161,458
Loss on legal settlement	0	26,924
Gain on settlement of accounts payable	(397,962)	(50,366)
Gain on conversion of accrued salary	(6,988)	0
Gain on derivative liabilities	(498,095)	69,611
Derivative expense	125,869	460,375
Amortization of discount on notes payable	785,724	603,861
Amortization of loan fees	18,000	0
Stock based compensation	259,307	154,558
Imputed interest	0	6,750
Changes in assets and liabilities:
Prepaid expenses	5,937	2,500
Accounts payable and accrued liabilities	371,972	184,398
Due to related parties	0	150,407
Other current liabilities	1,634	0
Accrued interest	89,642	57,017
Net cash provided by (used in) operating activities	(1,191,991)	(418,275)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable, net of payments to vendors	1,381,406	428,058
Principal payments on notes payable	(171,000)	(10,236)
Net cash provided by financing activities	1,210,406	417,822
Net increase (decrease) in cash and cash equivalents	18,415	(453)
Cash and cash equivalents at beginning of period	83,245	1,304
Cash and cash equivalents at end of period	101,660	851
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	2,680	2,236
Income taxes paid	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Par value of shares returned for cancellation	0	7,000
Shares issued for debt conversion	617,000	363,285
Shares issued for accrued salary conversion	17,787	0
Stock issued for legal settlement	0	101,028
Discount due to warrants	0	34,500
Beneficial conversion feature	0	223,087
Debt issued to related party for settlement of accounts payable	0	5,000
Settlement of derivative liabilities	1,020,449	203,730
Issuance of Series A Preferred Stock to consultants	71,558	0
Preferred stock dividends payable	56,143	0
Exercise of cashless warrants	50,986	0
Derivative discounts	999,800	470,000
Accrued interest converted to equity	$ 36,983	$ 26,330

Description of Business

Description of Business	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 – Description of Business Company Overview Mitesco, Inc. (the “Company,” “we,” “us,” or “our”) was formed in the state of Delaware on January 18, 2012. On December 9, 2015, we restructured our operations and acquired Newco4pharmacy, LLC, a development stage company which sought to acquire compounding pharmacy businesses. As a part of the restructuring, we completed a “spin out” of our former business line. On April 24, 2020, we changed our name to Mitesco, Inc. During 2020, our operations have focused on establishing medical clinics utilizing nurse practitioners under The Good Clinic name and development and acquisition of telemedicine technology. In March of 2020, we formed The Good Clinic LLC, a Colorado limited liability company for our clinic business. We entered into an agreement with four senior executives from Minute Clinic James Woodburn, Kevin Lee Smith, Michael Howe and Rebecca Hafner-Fogarty ( the “Sellers”) with the skills and know-how to assist the Company in the establishment of a series of clinics utilizing nurse practitioners and telemedicine technology in States where full practice authority for nurse practitioners is supported. We issued 4,800 shares of our Series A Preferred Stock to these individuals as compensation. We valued the 4,800 shares of the Series A Preferred Stock at $71,558 or approximately $14.91 per share based upon an analysis performed by an independent valuation consultant. We plan to open our first The Good Clinic in Minneapolis, MN in the first quarter of 2021.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2 – Summary of Significant Accounting Policies Basis of Accounting Use of Estimates - Other Comprehensive Loss - Cash - Revenue Recognition – Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We determine revenue recognition through the following steps: ● identification of the contract, or contracts, with a customer; ● identification of the performance obligations in the contract; ● determination of the transaction price; ● allocation of the transaction price to the performance obligations in the contract; and ● recognition of revenue when, or as, we satisfy a performance obligation. Stock-Based Compensation - The following assumptions were used for the valuation of the Series A Preferred Stock as of March 2, 2020: An Option Pricing Methodology (“OPM”) was utilized to allocate the enterprise value to the various equity linked instruments. The assumptions utilized in the OPM included a term of 5 years as the term for liquidity, a corresponding risk–free rate based on the term, 10% dividends, and a volatility based on the remaining term (based on comparable company volatility analysis): Market Cap (fully diluted basis) 3,749,829 Volatility (12 Months) 78.6 % Years to Liquidity 5.00 Continuous Risk Free Rate 0.88 % Stock Price $ 0.0419 Equity instruments issued to those other than employees are recognized pursuant to FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. This ASU relates to the accounting for non-employee share-based payments. The amendment in this update expands the scope of Topic 718 to include all share-based payment transactions in which a grantor acquired goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The ASU excludes share-based payment awards that relate to: (1) financing to the issuer; or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Topic 606, Revenue from Contracts from Customers. The share-based payments are to be measured at grant-date fair value of the equity instruments that the entity is obligated to issue when the goods or service has been delivered or rendered and all other conditions necessary to earn the right to benefit from the equity instruments have been satisfied. This standard will be effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. We adopted the provisions of this ASU on January 1, 2019. The adoption had no impact on our results of operations, cash flows, or financial condition. Convertible Instruments The following assumptions were used for the valuation of the derivative liability related to the convertible notes that contain a derivative component during the three months ended September 30, 2020: - The stock prices of $0.0296 to $0.079 in these periods would fluctuate with the Company projected volatility; - The projected volatility curve from an annualized analysis for each valuation period was based on the historical volatility of the Company and the term remaining for each note or warrant ranged from 135.6% through 198.5% at derivative treatment, issuance, conversion, exercise, and quarters ends. The Company continues to trade with high volatility; - The Holder would automatically convert the note at the maximum of 2 times the conversion price if the company was not in default. - The Holder would automatically convert the note before maturity if the registration was effective and the company was not in default. The Holder would automatically convert the note early based on ownership or trading volume limitations and the Company would redeem the unconverted balances at maturity. - A change of control and fundamental transaction would occur initially 0% of the time and increase monthly by 0% to a maximum of 0% – based on management being in control and no desire to sell the Company. - A reset event would adjust the Notes conversion price triggered by either a capital raise; stock issuance; settlement; or conversion/exercise (a reset occurred in this period on 11/7/19 – Auctus Conversion triggered a reset to $0.00858). The reset events are projected to occur annually starting 3 months following the date of valuation 9/30/20. - For the variable rate Notes (39% or 45% discount), the Holder would convert with effective discount rates of 50.28% to 55.17% (based on the lookback terms). - The Company would redeem the notes at maturity if the conversion value was less than the payment with penalties. For the majority of the notes during the period redemption is projected 0% of the time, increasing 0% per month to a maximum of 0%. - The cash flows are discounted to net present values using risk free rates. Discount rates were based on risk free rates in effect based on the remaining term. - An event of default would occur 10% of the time, increasing 0% per month to a maximum of 10%. Common Stock Purchase Warrants- Stockholders’ Equity- Per Share Data- The Company excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are antidilutive for the periods presented. As of September 30, 2020, there were 9,767,879 options and 63,188,385 shares issuable in connection with convertible debt excluded from calculation of diluted net loss; as of September 30, 2019, the Company had outstanding 1,425,000 warrants, 67,879 options, and 36,135,065 shares issuable in connection with convertible debt which were excluded from the calculation of diluted net loss. The Company, at its discretion, may satisfy the accrued interest on its Series A and Series X Preferred Stock via the issuance of shares of common stock; at September 30, 2020 and December 31, 2019, there were 1,731,740 and 0 shares, respectively, potentially issuable in connection with such issuance. Income Taxes- Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the condensed consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012. Business Combinations- ● future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and ● discount rates utilized in valuation estimates. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the condensed consolidated financial position, statements of operations or cash flows in the period of the change in the estimate. Impairment of Long-Lived Assets- Financial Instruments and Fair Values- Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable. Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates. Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs and their significance in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the derivative liabilities approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the derivative liabilities as Level 3. Recently Issued Accounting Standards-

Financial Condition and Going C

Financial Condition and Going Concern	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	N ote 3 – Financial Condition and Going Concern As of September 30, 2020, the Company had cash of $101,660, current liabilities of $2,720,646, and has incurred a loss from operations. The Company’s principal operation is the development and deployment of software and systems for the healthcare marketplace. The Company intends to: a) develop and own primary care clinics operated by nurse practitioners, b) develop and acquire telemedical technologies, and c) other healthcare related opportunities both domestically and on an international basis. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to execute its business plan. As a result of these factors, there is substantial doubt about the ability of the Company to continue as a going concern. The Company’s continuance is dependent on raising capital and generating revenues sufficient to sustain operations. The Company believes that the necessary capital will be raised and has entered discussions to do so with certain individuals and companies. However, as of the date of these condensed consolidated financial statements, no formal agreement exists. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions. During March 2020, in response to the COVID-19 crisis, the federal government announced plans to offer loans to small businesses in various forms, including the Payroll Protection Program, or "PPP", established as part of the Corona Virus Aid, Relief and Economic Security Act (“CARES Act”) and administered by the U.S. Small Business Administration. On April 18, 2020, the Company’s former President and COO completed and submitted an application on behalf of the Company to Bank of America, NA (“Bank of America”) for a PPP loan, which was subsequently approved. On April 25, 2020 the Company entered into an unsecured Promissory Note (the “Note”) with Bank of America for a loan in the original principal amount of $460,406, and the Company received the full amount of the loan proceeds on May 4, 2020. On July 21, 2020, Bank of America notified the Company in writing that it should not have received $440,000 of the loan proceeds disbursed under the Note. The Company investigated the terms of the application and discovered its former President had erroneously represented it was refinancing an Economic Injury Disaster Loan when no such loan had been received. Bank of America has requested that the Company remit the funds received back to Bank of America. The Company is currently working with Bank of America on a repayment plan. If we are not successful in negotiating repayment terms, it could have a material adverse effect on our financial condition. During management's review of the loan application after the loan had been disbursed to the Company, it was determined that the information provided by its former President and COO in the application was not representative of the Company’s situation. After consulting with legal counsel and conferring with the Board of Directors, the Board of Directors, in executive session, voted to remove the Company’s former President and Chief Operating Officer (“COO”) from its Board of Directors, and all operating roles due to the inaccuracy of the loan application. Subsequent to that decision, the former President & COO submitted a resignation from all positions with the Company, which was accepted by the Board and management. In August 2020, the former President and COO filed a complaint alleging discrimination under certain provisions of the anti-discrimination laws of that state. The Company believes that the action is without merit and it intends to vigorously defend itself. The Company does not believe it the action will have a material impact on the Company. We have had some impact on our operations as a result of the effect of the pandemic, primarily with accessibility to staffing, consultants and in the capital markets, and we are adjusting as needed within our available resources. The Company will continue to assess the effect of the pandemic on its operations. The extent to which the COVID-19 pandemic will impact the Company’s business and operations will depend on future developments that are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the outbreak, the duration and effect of possible business disruptions and the short-term effects and ultimate effectiveness of the travel restrictions, quarantines, social distancing requirements and business closures in the United States and other countries to contain and treat the disease. While the potential economic impact brought by, and the duration of, COVID-19 may be difficult to assess or predict, a widespread pandemic could result in significant disruption of global financial markets, reducing the Company’s ability to access capital, which could in the future negatively affect the Company’s liquidity. In addition, a recession or market correction resulting from the spread of COVID-19 could materially affect the Company’s business and the value of its securities.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 4 – Related Party Transactions Related party transactions for the nine months ended September 30, 2020 were as follows: On February 27, 2020, the Company agreed to issue 1,000,000 ten-year options to its two non-management directors (a total of 2,000,000 options). These options have a fair value at issuance of $39,162 per director (a total of $78,324), an exercise price of $0.05 per share, and vest over a three-year period. The Company valued these options using the Black-Scholes valuation model. During the nine- months ended September 30, 2020, the amount of $12,876 was charged to operations in connection with each 1,000,000-option grant (a total of $25,752 for all 2,000,000 options). On March 2, 2020, the Company agreed to issue 1,500,000 ten-year options to each of its Chief Executive Officer, its President, and a consultant (a total of 4,500,000 options). These options had a fair value at issuance of $58,743 per individual (a total of $176,229), an exercise price of $0.05 per share, and vest over a three-year period. The Company valued these options using the Black-Scholes valuation model. Julie Smith, the Company’s former President, Chief Operating Officer, and a Board member resigned effective June 30, 2020; the 1,500,000 options that the Company agreed to issue to Ms. Smith were cancelled; a total of $1,632 was charged to operations representing the fair value of these options through Ms. Smith’s resignation date. During the nine months ended September 30, 2020, the amount of $39,432 was charged to operations in connection with each of the remaining 1,500,000 option grants (a total of $78,864 for all 3,000,000 remaining options). On June 1, 2020, the Company agreed to issue 1,000,000 ten-year options to a non-management director. These options have a fair value of $28,460, an exercise price of $0.03 per share, and vest over a three-year period. The Company valued these options using the Black-Scholes valuation model. During the nine months ended September 30, 2020, the amount of $9,487 was charged to operations in connection these options. On August 1, 2020, the Company agreed to issue 1,000,000 ten-year options to a non-management director. These options have a fair value of $56,037, an exercise price of $0.05 per share, and vest over a three-year period. The Company valued these options using the Black-Scholes valuation model. During the nine months ended September 30, 2020, the amount of $11,595 was charged to operations in connection these options. During the nine months ended September 30, 2020, the Company charged the amount of $69,342 to operations in connection with the vesting of restricted common stock as follows: $27,196 for shares issued to management; $26,511 for shares issued to board members; and $15,635 related to shares issued to an employee. Julie Smith, our former President, Chief Operating Officer, and a Board member, resigned effective June 30, 2020; at the time of her resignation, a total of 1,000,000 shares of the Company’s common stock issued to Ms. Smith for compensation as a board member were vested, and remain outstanding; an additional 250,000 shares of common stock issued to Ms. Smith for compensation as an officer were vested, and also remain outstanding; 750,000 shares of common stock to be issued to Ms. Smith for compensation as an officer had not vested, and these shares were cancelled. During the nine months ended September 30, 2020, the Company accrued dividends on its Series X Preferred stock in the total amount of $49,176. Of this amount, a total of $9,750 was payable to officers and directors,$23,443 was payable to a related party shareholder, and $15,983 was payable to non-related parties. Related party transactions for the nine months ended September 30, 2019 were as follows: On March 11, 2019, the Company issued 100,000 shares of common stock to its President as compensation and charged the fair value in the amount of $8,740 to operations. On March 11, 2019, the Company issued 100,000 shares of common stock to a board member as compensation and charged the fair value in the amount of $8,740 to operations. On July 29, 2019, the Company cancelled 300,000 shares of common stock previously issued to its former President. The par value of these shares in the amount of $3,000 was charged to paid-in capital during the three months ended September 30, 2019. On August 10, 2019, the Company issued 1,000,000 shares of common stock with a fair value of $60,000 to a board member pursuant to a director advisory agreement. The fair value of these shares will be recognized ratably over the vesting period; during the three months ended September 30, 2019, the amount of $37,054 was charged to operations in connection with these shares. On August 10, 2019, the Company issued 775,000 shares of common stock with a fair value of $46,500 to a board member pursuant to a director advisory agreement. The fair value of these shares will be recognized ratably over the vesting period; during the three months ended September 30, 2019, the amount of $28,325 was charged to operations in connection with these shares. On August 10, 2019, the Company issued 200,000 shares of common stock with a fair value of $12,000 to a board member pursuant to a director advisory agreement. The fair value of these shares will be recognized ratably over the vesting period; during the three months ended September 30, 2019, the amount of $12,000 was charged to operations in connection with these shares. During the nine months ended September 30, 2019, the Company accrued the amount of $2,875 in connection with the vested portion of a common stock award granted to its President. At September 30, 2019, the Company has the following amounts due to related parties: - Due to shareholders for consulting services, accounts payable paid on behalf of the Company, and accrued interest: $169,355 - Note payable in the amount of $75,000 related to reclassification of accounts payable (see note 5, “July 2017 Note”) - Note payable in the amounts of $65,000 related to consulting services provided (see note 5, “Consulting Services Note”) - Note payable in the amounts of $58,000 related to accounts payable paid on behalf of the Company (see note 5, “Trade Payables Note”)

Debt

Debt	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 5 – Debt August 2014 Series C Convertible Debenture As part of the restructuring, all debentures issued by Trunity Holdings, Inc., to fund the former, educational business, were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series C Convertible Debenture (the “Series C Debenture”) in August 2014 with an aggregate face value of $100,000 in exchange for the cancellation of Series B Convertible Debentures with a carrying value of $110,833 did not convert such debenture. The Series C Convertible Debenture accrues interest at an annual rate of 10%, matured November 2015, and is convertible into our common stock at a conversion rate of $20.20 per share. The holders of the Series C Debenture also received five-year warrants to acquire up to 4,950 shares post-split of common stock for an exercise price of $20.20 per share. The former educational business allocated the face value of the Series C Debenture to the warrants and the debentures based on its relative fair values, and allocated to the warrants, which was recorded as a discount against the Series C Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. The Series C Debenture is currently in default. Details of activity for the three months ended September 30, 2020 are presented in Notes Payable Table 1, below. November 2014 Series D Convertible Debenture As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series D Convertible Debenture (the “Series D Debenture”) in November 2014 with an aggregate face value of $10,000 in exchange for the cancellation of Series B Convertible Debenture with a carrying value of $11,333 did not participate in the debt conversion restructuring. The Series D Debenture accrues interest at an annual rate of 12%, matured November 2015, and is convertible into our common stock at a conversion rate of $16.67 per share. The holders of the Series D Debenture also received five-year warrants to acquire up to 495 shares of common stock for an exercise price of $20.20 per share on a post-split basis. The former educational business allocated the face value of the Series D Debenture to the warrants and the debentures based on their relative fair values, and allocated to the warrants, which was recorded as a discount against the Series D Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. The Series D Debenture is currently in default. Details of activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. March 2016 Convertible Note A On March 18, 2016, the Company issued a 12% Convertible Promissory Note (the “Convertible Note A”) in the principal amount of $60,000 to a lender. Pursuant to the terms of the Convertible Note A, the Company is obligated to pay monthly installments of not less than $1,000 the first of each month commencing the month following the execution of the Convertible Note A until its maturity on September 16, 2016 at which time the Company was obligated to repay the full principal amount of the Convertible Note A. The Convertible Note A is convertible by the holder at any time into shares of the Company’s common stock at price of $1.00 per share, and throughout the duration of the note, the holder has the right to participate in any financing the Company may engage in upon the same terms and conditions as all other investors. The Company allocated the face value of the Convertible Note A to the shares and the note based on relative fair values, and the amount allocated to the shares of $18,750 was recorded as a discount against the note. The beneficial conversion feature of $9,375 was recorded as a debt discount with an offsetting entry to additional paid-in capital decreasing the note payable and increasing debt discount. The debt discount was amortized to interest expense during the year ended December 31, 2016. Upon issuance of the Convertible Note A, the lender was awarded 15,000 restricted common stock as an origination fee which includes piggy-back registration rights. On September 19, 2016, the Company issued the lender an additional 15,000 restricted common stock at a price of $0.30 per share to extend the term of the loan agreement indefinitely. The cost to the Company was $4,050 in interest expense. On August 10, 2017, the Company issued 25,000 shares of common stock with a fair value of $3,750 for accrued interest through August 1, 2017 in the amount of $7,860. In April 2018, the Company issued 75,000 shares of common stock with a value of $7,500 as consideration for an extension of the term of the loan to July 1, 2018, and on August 13, 2018, the Company issued an additional 75,000 shares of common stock with a value of $6,750 for an extension of the term of the loan to October 31, 2018. During the year ended December 31, 2019, the lender converted principal in the amount of $15,000 into 120,000 shares of common stock. The Company recorded a loss in the amount of $13,867 on this conversion. Also, during the year ended December 31, 2019, the Company made a principal payment in the amount of $4,000 on this note. Details of activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. Power Up Note 11 On September 12, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 11”) in the aggregate principal amount of $45,000. The Power Up Note 11 entitles the holder to 12% interest per annum and matures on July 15, 2020. Under the Power Up Note 11, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 11 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 11, at a price equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price shall mean 55% of lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 11 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 11 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 115%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 11, then such redemption premium is 120%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 125%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 130%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 135%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Power Up Note 11, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 11; $3,000 was amortized to interest expense during the year ended December 31, 2019. The Company accrued interest in the amount of $1,642 on the Power Up Note 11 during the year ended December 31, 2019. During the year ended December 31, 2019, the Company determined that a derivative liability in the amount of $47,187 existed in connection with the variable rate conversion feature of the Power Up Note 11. $45,000 of this amount was charged to discount on the Power Up Note 11, and $2,187 was charged to interest expense. During the nine months ended September 30, 2020, the Company made a cash payment in the amount of $74,195 on the Power Up Note 11 which fully satisfied this obligation. This amount consisted of $45,000 of principal, $2,680 of accrued interest, and $23,815 of prepayment penalty. The Company revalued the derivative liability associated with the Power Up Note 11 at the time of payment, and recorded a gain on revaluation in the amount of $35,420. The Company credited the fair value of the derivative liability at the time of payment in the amount of $21,266 to additional paid-in capital. Details of additional activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. This obligation has been fully satisfied and the Company has no further requirements related to this matter. Power Up Note 12 On October 7, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 12”) in the aggregate principal amount of $53,000 and an original issue discount of $3,000. The Power Up Note 12 entitles the holder to 12% interest per annum and matures on August 15, 2020. Under the Power Up Note 12, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 12 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 12, at a price equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price shall mean 55% of lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 12 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 12 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 115%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 12, then such redemption premium is 120%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 125%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 130%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 135%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Power Up Note 12, there shall be no further right of prepayment. The Company accrued interest in the amount of $1,499 on the Power Up Note 12 during the year ended December 31, 2019. During the year ended December 31, 2019, the Company determined that a derivative liability in the amount of $54,969 existed in connection with the variable rate conversion feature of the Power Up Note 12. $53,000 of this amount was charged to discount on the Power Up Note 12, and $2,187 was charged to interest expense. $6,502 of the discount was charged to operations during the year ended December 31, 2019. During the three months ended September 30, 2020, the Company made a cash payment in the amount of $84,231 on the Power Up Note 12 which fully satisfied this obligation. This amount consisted of $53,000 of principal, $3,312 of accrued interest, and $27,919 of prepayment penalty. The Company revalued the derivative liability associated with the Power Up Note 12 at the time of payment, and recorded a gain on revaluation in the amount of $4,247. The Company credited the fair value of the derivative liability at the time of payment in the amount of $62,569 to additional paid-in capital. Details of additional activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. This obligation has been fully satisfied and the Company has no further requirements related to this matter. Power Up Note 13 On November 11, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 13”) in the aggregate principal amount of $73,000 and an original issue discount of $3,000. The Power Up Note 13 entitles the holder to 12% interest per annum and matures on August 30, 2020. Under the Power Up Note 13, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 13 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 12, at a price equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price shall mean 55% of lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 13 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 13 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 115%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 13, then such redemption premium is 120%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 125%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 130%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 135%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Power Up Note 13, there shall be no further right of prepayment. The Company accrued interest in the amount of $1,414 on the Power Up Note 13 during the year ended December 31, 2019. During the year ended December 31, 2019, the Company determined that a derivative liability in the amount of $73,529 existed in connection with the variable rate conversion feature of the Power Up Note 13. $73,000 of this amount was charged to discount on the Power Up Note 13, and $529 was charged to interest expense. $6,091 of the discount was charged to operations during the year ended December 31, 2019. During the three months ended June 30, 2020, the Company made a cash payment in the amount of $115,980 on the Power Up Note 13 which fully satisfied this obligation. This amount consisted of $73,000 of principal, $4,728 of accrued interest, and $38,252 of prepayment penalty. The Company revalued the derivative liability associated with the Power Up Note 13 at the time of payment, and recorded a gain on revaluation in the amount of $4,882. The Company credited the fair value of the derivative liability at the time of payment in the amount of $86,380 to additional paid-in capital. Details of additional activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. This obligation has been fully satisfied and the Company has no further requirements related to this matter. Eagle Equities Note 1 On November 22, 2019, the Company entered into a Securities Purchase Agreement with Eagle Equities, LLC (“Eagle Equities”) pursuant to which Eagle Equities agreed to purchase a convertible promissory note (the “Eagle Equities Note 1”) in the aggregate principal amount of $256,000 and an original issue discount of $6,000. The Eagle Equities Note 1 entitles the holder to 12% interest per annum and matures on November 22, 2020. Under the Eagle Equities Note 1, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 1 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 1, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 1 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Eagle Equities Note 1 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 1, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 1, there shall be no further right of prepayment. The Company accrued interest in the amount of $3,367 on the Eagle Equities Note 1 during the year ended December 31, 2019. During the year ended December 31, 2019, the Company determined that a derivative liability in the amount of $271,694 existed in connection with the variable rate conversion feature of the Eagle Equities Note 1. $256,000 of this amount was charged to discount on the Eagle Equities Note 1, and $15,694 was charged to interest expense. $7,784 of the discount was charged to operations during the year ended December 31, 2019. During the nine months ended September 30, 2020, the holder of the Eagle Equities Note 1 converted the following amounts of principal and accrued interest to common stock: On June 5, 2020, principal of $25,000 and accrued interest of $1,608 were converted at a price of $0.0132 per share into 2,015,783 shares of common stock; On June 17, 2020, principal of $25,000 and accrued interest of $1,708 were converted at a price of $0.0132 per share into 2,023,358 shares of common stock; On June 23, 2020, principal of $40,000 and accrued interest of $2,813 were converted at a price of $0.0132 per share into 3,243,434 shares of common stock; on June 26, 2020, principal of $26,000 and accrued interest of $1,855 were converted at a price of $0.01362 per share into 2,045,130 shares of common stock; on July 9, 2020, principal of $45,000 and accrued interest of $3,405 were converted at a price of $0.01518 per share into 3,188,735 shares of common stock; on July 17, 2020, principal of $50,000 and accrued interest of $3,917 were converted at a price of $0.01572 per share into 3,429,814 shares of common stock; and on July 30, 2020, principal of $45,000 and accrued interest of $3,720 were converted at a price of $0.021 per share into 2,320,000 shares of common stock. There were no gains or losses recorded, as these conversions were made pursuant to the terms of the agreement. Details of activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. This obligation has been fully satisfied and the Company has no further requirements related to this matter. Eagle Equities Note 2 On December 19, 2019, the Company entered into a Securities Purchase Agreement with Eagle Equities pursuant to which Eagle Equities agreed to purchase a convertible promissory note (the “Eagle Equities Note 2”) in the aggregate principal amount of $256,000 and an original issue discount of $6,000. The Eagle Equities Note 2 entitles the holder to 12% interest per annum and matures on December 19, 2020. Under the Eagle Equities Note 2, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 2 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 2, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 2 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Eagle Equities Note 2 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 2, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 2, there shall be no further right of prepayment. The Company accrued interest in the amount of $1,094 on the Eagle Equities Note 2 during the year ended December 31, 2019. During the year ended December 31, 2019, the Company determined that a derivative liability in the amount of $277,476 existed in connection with the variable rate conversion feature of the Eagle Equities Note 2. $256,000 of this amount was charged to discount on the Eagle Equities Note 2, and $21,476 was charged to interest expense. $8,393 of the discount was charged to operations during the year ended December 31, 2019. During the nine months ended September 30, 2020, the holder of the Eagle Equities Note 2 converted the following amounts of principal and accrued interest to common stock: On August 20, 2020, principal of $56,000 and accrued interest of $4,573 were converted at a price of $0.01896 per share into 3,194,796 shares of common stock; On September 1, 2020, principal of $50,000 and accrued interest of $4,283 were converted at a price of $0.01806 per share into 3,005,721 shares of common stock; On September 9, 2020, principal of $50,000 and accrued interest of $4,417 were converted at a price of $0.0153 per share into 3,556,645 shares of common stock; and on September 25, 2020, principal of $50,000 and accrued interest of $4,683 were converted at a price of $0.0153 per share into 3,574,074 shares of common stock. Details of activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. This obligation has been fully satisfied and the Company has no further requirements related to this matter. Eagle Equities Note 3 On January 24, 2020, the Company entered into a Securities Purchase Agreement with Eagle Equities pursuant to which Eagle Equities agreed to purchase a convertible promissory note (the “Eagle Equities Note 3”) in the aggregate principal amount of $256,000 and an original issue discount of $6,000. The Eagle Equities Note 3 entitles the holder to 12% interest per annum and matures on January 24, 2021. Under the Eagle Equities Note 3, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 3 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 3, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 3 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Eagle Equities Note 3 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 3, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 3, there shall be no further right of prepayment. During the three months ended March 31, 2020, the Company determined that a derivative liability in the amount of $272,412 existed in connection with the variable rate conversion feature of the Eagle Equities Note 3. $250,000 of this amount was charged to discount on the Eagle Equities Note 3, and $22,412 was charged to interest expense. Details of additional activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. Eagle Equities Note 4 On March 10, 2020, the Company entered into a Securities Purchase Agreement with Eagle Equities pursuant to which Eagle Equities agreed to purchase a convertible promissory note (the “Eagle Equities Note 4”) in the aggregate principal amount of $129,000 and an original issue discount of $4,000. The Eagle Equities Note 4 entitles the holder to 12% interest per annum and matures on March 10, 2021. Under the Eagle Equities Note 4, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 4 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 4, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 4 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Eagle Equities Note 4 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 4, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 4, there shall be no further right of prepayment. During the three months ended March 31, 2020, the Company determined that a derivative liability in the amount of $139,021 existed in connection with the variable rate conversion feature of the Eagle Equities Note 4. $125,000 of this amount was charged to discount on the Eagle Equities Note 4, and $14,021 was charged to interest expense. Details of additional activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. As of the November 5, 2020, the remaining principal balance on this note was $156,000 and accrued interest was $14,643. Eagle Equities Note 5 On April 8, 2020, the Company entered into a Securities Purchase Agreement with Eagle Equities pursuant to which Eagle Equities agreed to purchase a convertible promissory note (the “Eagle Equities Note 5”) in the aggregate principal amount of $100,000 and an original issue discount of $4,000. The Eagle Equities Note 5 entitles the holder to 12% interest per annum and matures on April 8, 2021. Under the Eagle Equities Note 5, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 5 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 5, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 5 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Eagle Equities Note 5 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 5, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 5, there shall be no further right of prepayment. During the three months ended June 30, 2020, the Company determined that a derivative liability in the amount of $106,576 existed in connection with the variable rate conversion feature of the Eagle Equities Note 5. $100,000 of this amount was charged to discount on the Eagle Equities Note 5, and $6,576 was charged to interest expense. Details of additional activity for the three and nine months ended September 30, 2020 are presented in Notes Payable Table 1, below. Eagle Equities Note 6 On July 1, 2020, the Company entered into a Securities Purchase Agreement with Eagle Equities pursuant to which Eagle Equities agreed to purchase a convertible promissory note (the “Eagle Equities Note 6”) in the aggregate principal amount of $200,200 with an original issue discount of $18,200. The amount received was also net of fees in the amount of $7,000, which were charged to interest expense during the period. The Eagle Equities Note 6 entitles the holder to 12% interest per annum and matures on July 1, 2021. Under the Eagle Equities Note 6, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 6 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 6, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 6 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Eagle Equities Note 6 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 6, then such redemption premium is 116%; if

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Sep. 30, 2020
Disclosure Text Block [Abstract]
Derivatives and Fair Value [Text Block]	Note 6 – Derivative Liabilities Certain of the Company’s convertible notes and warrants contain features that create derivative liabilities. The pricing model the Company uses for determining fair value of its derivatives is the Lattice Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income. The derivative components of these notes are valued at issuance, at conversion, at restructure, and at each period end. Derivative liability activity for the year ended December 31, 2019 and the nine months ended September 30, 2020 is summarized in the table below: December 31, 2018 $ - Conversion features issued 1,472,320 Warrants issued 187,968 Settled upon conversion or exercise (689,469 ) Settled upon payment of note (191,827 ) Loss on revaluation 709,431 December 31, 2019 $ 1,488,423 Conversion features issued 1,068,870 Settled upon conversion or exercise (1,020,450 ) Settled upon payment of note (148,949 ) Gain on revaluation (263,042 ) September 30, 2020 $ 1,124,852

Stockholders' (Equity)

Stockholders' (Equity)	9 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 7 – Stockholders’ (Equity) Common Stock The Company has authorized 500,000,000 shares of common stock, par value $0.01; 121,452,914 and 81,268,443 shares were issued and outstanding at September 30, 2020 and December 31, 2019, respectively. Common Stock Transactions During the Nine Months Ended September 30, 2020 On May 27, 2020, the Company issued 2,901,440 shares of common stock for the cashless exercise of warrants. These warrants were issued pursuant to a settlement agreement with a note holder regarding the effective price of warrants issued with regard to a variable conversion price feature which resulted in the issuance of 1,011,967 more shares than would have been issued prior to the settlement agreement. The Company recorded a loss in the amount of $24,894 on this transaction based upon the additional shares issued at the market price of the Company’s common stock. The holder of the Eagle Equities Note 1 converted the following amounts of principal and accrued interest to common stock: On June 5, 2020, principal of $25,000 and accrued interest of $1,608 were converted at a price of $0.0132 per share into 2,015,783 shares of common stock; On June 17, 2020, principal of $25,000 and accrued interest of $1,708 were converted at a price of $0.0132 per share into 2,023,358 shares of common stock; On June 23, 2020, principal of $40,000 and accrued interest of $2,813 were converted at a price of $0.0132 per share into 3,243,434 shares of common stock; on June 26, 2020, principal of $26,000 and accrued interest of $1,855 were converted at a price of $0.01362 per share into 2,045,130 shares of common stock; on July 9, 2020, principal of $45,000 and accrued interest of $3,405 were converted at a price of $0.01518 per share into 3,188,735 shares of common stock; on July 17, 2020, principal of $50,000 and accrued interest of $3,917 were converted at a price of $0.01572 per share into 3,429,814 shares of common stock; and on July 30, 2020, principal of $45,000 and accrued interest of $3,720 were converted at a price of $0.021 per share into 2,320,000 shares of common stock. There were no gains or losses recorded, as these conversions were made pursuant to the terms of the agreement. The holder of the Eagle Equities Note 2 converted the following amounts of principal and accrued interest to common stock: On August 20, 2020, principal of $56,000 and accrued interest of $4,573 were converted at a price of $0.01896 per share into 3,194,796 shares of common stock; On September 1, 2020, principal of $50,000 and accrued interest of $4,283 were converted at a price of $0.01806 per share into 3,005,721 shares of common stock; On September 9, 2020, principal of $50,000 and accrued interest of $4,417 were converted at a price of $0.0153 per share into 3,556,645 shares of common stock; and on September 25, 2020, principal of $50,000 and accrued interest of $4,683 were converted at a price of $0.0153 per share into 3,574,074 shares of common stock. On January 2, 2020, the Company issued 200,000 restricted shares of the Company’s common stock at valued $7,680 in exchange for services conducted on behalf of the Company. The value of these shares was based on the closing market price on the respective date of grant. The Company charged the amount of $69,342 to operations in connection with the vesting of stock granted to its officers and board members; the Company also charged the amount of $128,714 to operations in connection with the vesting of options granted to officers, board members and employees. On March 2, 2020, the Company entered into agreements to issue 500,000 options to each of four consultants (a total of 2,000,000 options). The options have a fair value of $20,930 per consultant (a total of $83,720). These agreements will become effective April 6, 2020, at which time the Company will begin to charge the value of these options to operations. The Company valued these options using the Black-Scholes valuation model. The Company entered into agreements with two note holders regarding the exercise price of warrants held by the note holders. These agreements resulted in the following: (i) on January 29, 2020, the Company issued 1,000,000 shares of common stock, and the note holders agreed to cancel 2,769,482 warrants; the Company recorded a gain in the amount of $77,652 on this transaction; (ii) on February 19, 2020, the Company issued 4,098,556 shares of common stock for the exercise of 4,480,938 warrants in a cashless transaction; the Company recorded a gain in the amount of $259,947 on this transaction, which is included in gain on derivative liabilities. On August 27, 2020, the Company issued 386,985 shares of common stock at a price of $0.034 per share to an ex-employee for accrued compensation. A gain in the amount of $6,988 was recognized on this transaction. Common Stock Transactions During the Nine Months Ended September 30, 2019 The Company issued 200,000 restricted shares of the Company’s common stock at valued $17,480 in exchange for services conducted on behalf of the Company. The value of these shares was based on the closing market price on the respective date of grant. The Company issued 2,975,000 shares of common stock to employees, subject to vesting provisions, pursuant to employment agreements. The par value of these shares in the amount of $29,750 was credited to paid-in capital. The Company charged the amount of $2,875 to additional paid-in capital in connection with the vesting of stock granted to its President. The Company issued, in twenty-four transactions, a total of 14,394,002 shares in connection with the conversion of notes payable principal, accrued interest and fees in the aggregate amounts of $368.882, $26,330, and $1,500, respectively; a loss in the aggregate amount of $161,458 was recognized on these transactions. The Company cancelled an aggregate 700,000 shares of common stock issued to former executive officers. The Company issued 1,401,224 shares of common stock in connection with the settlement of a note payable in the amount of $74,104. The Company recorded a loss in the amount of $26,924 in connection with this transaction. Preferred Stock We are authorized to issue: ● 500,000,000 shares of Common Stock of which 121,452,914 shares are outstanding, and 9,917,879 common shares which are issuable upon exercise of warrants and options. We are also obligated to issue Common Stock upon conversion of certain promissory notes of approximately $1.3 million, or $1.5 million if held for an extended period of time. Most have a conversion feature that could allow the holder to convert to Common Stock at a 40% discount to the market price. ● 100,000,000 shares of Preferred Stock with such rights designations and preferences as determined by our board of directors. We have designated: o 27,324 shares as Series X Preferred Stock, and o 3,000,000 shares as Series A Preferred Stock, Series A Preferred Stock We issued 4,800 and 0 shares of our 12% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) as of September 30, 2020 and December 31, 2019, respectively. The Series A Preferred Stock has a par value of $0.01 per share, no stated maturity, a liquidation preference of $25.00 per share, and is not be subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless the Company decides to redeem or otherwise repurchase the Series A Preferred Stock. The Series A Preferred Stock is not redeemable prior to December 31, 2022. The Series A Preferred Stock will accrue dividends at the rate of 12% on $25.00 per share. The designation includes, among other terms, that: ■ The Series A Preferred Stock ranks junior to our Series X Preferred Stock; ■ The Series A Preferred Stock has limited voting rights only on matters impacting certain of our securities that are senior to the Series A and in transactions involving mergers or similar transactions that adversely affects and deprives holders of the Series A Preferred Stock; ■ The Series A Preferred Stock is on a parity with all equity securities issued by us with terms specifically providing that those equity securities rank on a parity with the Series A Preferred Stock with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up; ■ The Series A Preferred Stock is junior to all equity securities issued by us with terms specifically providing that those equity securities rank senior to the Series A Preferred Stock with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up; ■ The Series A Preferred Stock is effectively junior to all of our existing and future indebtedness; ■ The Series A Preferred Stock will remain outstanding indefinitely unless we decide to redeem or otherwise repurchase it at our option; ■ The Series A Preferred Stock will accrue cumulative cash dividends at the rate of 10% of the $25.00 per share liquidation preference per annum which will accrue if we do not have funds to pay the dividend; ■ We have not yet generated revenues from our current business plan and we do not presently have a reserve to pay dividends that will be due in the future on the Series A Preferred Stock; ■ No dividends will be paid or set apart for payment by us at any time if it would violate the terms of any agreement in which we are a party to or that we may enter into in the future; ■ 2,395,200 additional shares of the Series A Preferred Stock may be issued by us without the approval of shareholders; ■ The Series A Preferred Stock may be redeemed by us on or after December 31, 2022, for a cash redemption price of $25.00 per share if certain requirements are met; ■ The Series A Preferred Stock is not convertible into our Common Stock; and ■ If we fail to pay a dividend on the Series A Preferred, holders will not receive additional interest or fees in respect to such dividend. Series A Preferred Stock Transactions During the Nine Months Ended September 30, 2020 On March 2, 2020, the Company issued 4,800 shares of its Series A Preferred Stock to four individuals with certain skills and know-how to assist the Company in the development of its newly-formed subsidiary The Good Clinic, LLC. The Company has valued these shares at $71,558 or approximately $14.91 per share based upon an analysis performed by an independent valuation consultant. During the nine months ended September 30, 2020, the Company accrued dividends in the amount of $6,967 on the Series A Preferred Stock. At September 30, 2020, dividend payable on the Series A Preferred Stock was $6,967. At September 30, 2020, if management determined to pay these dividends in shares of the Company’s common stock, this would result in the issuance of 214,898 shares of common stock based upon the average price of $0.03242 per share for the five day period ended September 30, 2020. Series X Preferred Stock The Company has 26,227 shares of its 10% Series X Cumulative Redeemable Perpetual Preferred Stock (the “Series X Preferred Stock”) outstanding as of September 30, 2020 and December 31, 2019. The Series X Preferred Stock has a par value of $0.01 per share, no stated maturity, a liquidation preference of $25.00 per share, and will not be subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless the Company decides to redeem or otherwise repurchase the Series X Preferred Stock; the Series X Preferred Stock is not redeemable prior to November 4, 2020. The Series X Preferred Stock will rank senior to all classes of the Company’s common and preferred stock and accrues dividends at the rate of 10% on $25.00 per share. The Company reserves the right to pay the dividends in shares of the Company’s common stock at a price equal to the average closing price over the five days prior to the date of the dividend declaration. Each one share of the Series X Preferred Stock is entitled to 20,000 votes on all matters submitted to a vote of our shareholders. Series X Preferred Stock Transactions During the Nine Months Ended September 30, 2020 During the nine months ended September 30, 2020, the Company accrued dividends in the amount of $49,176 on the Series X Preferred Stock. At September 30, 2020, dividend payable on the Series X Preferred Stock was $49,176. At September 30, 2020, if management determined to pay these dividends in shares of the Company’s common stock, this would result in the issuance of 1,516,841 shares of common stock based upon the average price of $0.03242 per share for the five day period ended September 30, 2020. Stock Options The following table summarizes the options outstanding at September 30, 2020 and the related prices for the options to purchase shares of the Company’s common stock: Weighted Weighted Weighted average average average exercise exercise Range of Number of remaining price of Number of price of exercise options contractual outstanding options exercisable prices outstanding life (years) options exercisable options $ 0.03 1,250,000 9.67 $ 0.03 250,000 $ 0.03 $ 0.05 7,450,000 9.44 $ 0.05 983,334 $ 0.05 $ 0.06 1,000,000 9.84 $ 0.06 - $ - $ 21.40 67,879 2.41 $ 21.40 67,879 $ 1.16 9,767,879 9.46 $ 0.20 1,301,213 $ 1.16 Transactions involving stock options are summarized as follows: Shares Weighted- Average Exercise Price ($) Outstanding at December 31, 2018 67,879 $ 21.40 Granted - - Cancelled - - Outstanding at December 31, 2019 67,879 $ 21.40 Granted 11,200,000 $ 0.05 Cancelled (1,500,000 ) 0.05 Outstanding at September 30, 2020 9,767,879 $ 0.20 Exercisable at September 30, 2020 1,301,213 $ 1.16 At September 30, 2020, the total stock-based compensation cost related to unvested awards not yet recognized was $253,582. The Company valued warrants and stock options during the nine months ended September 30, 2020 and 2019 using the Black-Scholes valuation model utilizing the following variables: September 30, September 30, 2020 2019 Volatility 201.9% to 209.6 % 228.0% to 229.4 % Dividends $ - $ - Risk-free interest rates 0.55% to 1.30 % 1.75% to 2.53 % Term (years) 6.0 to 10.00 5.00 Warrants The following table summarizes the warrants outstanding at September 30, 2020 and the related prices for the warrants to purchase shares of the Company’s common stock: Shares Weighted- Average Exercise Price ($) Outstanding at December 31, 2018 1,167,653 $ 2.18 Granted 400,000 $ 0.00858 Additional warrants due to trigger of ratchet feature 6,659,382 $ 0.00858 Exercised – cashless conversion (3,514,900 ) $ 0.00858 Forfeited (2,769,482 ) $ 0.00858 Expired (142,653 ) 17.42 Outstanding at December 31, 2019 1,800,000 $ 0.00858 Granted 6,582,382 $ 0.00858 Exercised (8,382,382 ) $ 0.0561 Outstanding at September 30, 2020 - $ -

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 8 – Commitments and Contingencies Legal There are no pending or anticipated legal actions at this time except as noted below in “Other”. Other During management's review of the Company’s recent PPP loan application after the loan had been disbursed to the Company, it was determined that the information provided by Ms. Julie R. Smith, the Company’s former President and COO, was not representative of the Company’s situation. After consulting with legal counsel, the Board of Directors voted to remove Ms. Smith from its Board of Directors, and all other capacities due to the misstatements she made in the loan application. Subsequent to that decision, effective July 1, 2020, Ms. Smith submitted a resignation from all positions with the Company, which was accepted by the Board and management. Ms. Smith subsequently retained counsel and has indicated her intent to file an administrative charge of discrimination in Colorado under certain provisions of the anti-discrimination laws of that state. On August 18, 2020, the Company received formal notice that a complaint has been filed with the Colorado Civil Rights Division by Ms. Smith naming the Company as the Respondent. The Company believes the claims are frivolous and intends to vigorously defend against the allegations.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 9 – Subsequent Events Lease Agreement Effective October 19, 2020, the Company entered into an agreement to lease approximately 3,038 square feet of retail space from LMC NE Minneapolis Holdings, Inc. for purposes of operating its first medical clinic (the “LMC Lease”). The lease has an initial term of 90 months at the following rates: Months 1 to 24 - $5,317 per month; months 25 to 36 - $5,443 per month; months 37 to 48 - $5,570 per month; months 49 to 60 - $5,696 per month; months 61 to 72 - $5,823 per month; months 73 to 90 - $5,949 per month. The LMC Lease also provides the Company with renewal options for months 91 through 150. Convertible Note Agreement On October 29, 2020, the Company entered into a convertible redeemable note agreement with Eagle Equities, LLC in the amount of $114,400 (the “Eagle Equities Note 9). The Eagle Equities Note 9 bears interest at the rate of 12% per annum, is convertible into the Company’s common stock at any time after 180 days from the date of the note, and is due October 29, 2021. Common Stock Issued for Conversion of Notes Payable On October 6, 2020, the Company issued 3,586,057 shares of common stock at a price of $0.0153 per share pursuant to the conversion of $50,000 of principal and $4,867 of accrued interest in Eagle Equities Note 2. On October 15, 2020, the Company issued 3,471,690 shares of common stock at a price of $0.01566 per share pursuant to the conversion of $50,000 of principal and $4,367 of accrued interest in Eagle Equities Note 3. On October 29, 2020, the Company issued 4,439,024 shares of common stock at a price of $0.0123 per share pursuant to the conversion of $50,000 of principal and $4,600 of accrued interest in Eagle Equities Note 3. On November 11, 2020, the Company issued 3,259,369 shares of common stock at a price of $0.0111 per share pursuant to the conversion of $33,000 of principal and $3,179 of accrued interest in Eagle Equities Note 3. Amendment of Bylaws On November 10, the Company amended its bylaws to increase the number of members of its Board of Directors to up to 10 members and eliminate cumulative voting for the election of directors.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Accounting
Use of Estimates, Policy [Policy Text Block]	Use of Estimates -
Comprehensive Income, Policy [Policy Text Block]	Other Comprehensive Loss -
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash -
Revenue [Policy Text Block]	Revenue Recognition – Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We determine revenue recognition through the following steps: ● identification of the contract, or contracts, with a customer; ● identification of the performance obligations in the contract; ● determination of the transaction price; ● allocation of the transaction price to the performance obligations in the contract; and ● recognition of revenue when, or as, we satisfy a performance obligation.
Share-based Payment Arrangement [Policy Text Block]	Stock-Based Compensation - The following assumptions were used for the valuation of the Series A Preferred Stock as of March 2, 2020: An Option Pricing Methodology (“OPM”) was utilized to allocate the enterprise value to the various equity linked instruments. The assumptions utilized in the OPM included a term of 5 years as the term for liquidity, a corresponding risk–free rate based on the term, 10% dividends, and a volatility based on the remaining term (based on comparable company volatility analysis): Market Cap (fully diluted basis) 3,749,829 Volatility (12 Months) 78.6 % Years to Liquidity 5.00 Continuous Risk Free Rate 0.88 % Stock Price $ 0.0419 Equity instruments issued to those other than employees are recognized pursuant to FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. This ASU relates to the accounting for non-employee share-based payments. The amendment in this update expands the scope of Topic 718 to include all share-based payment transactions in which a grantor acquired goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The ASU excludes share-based payment awards that relate to: (1) financing to the issuer; or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Topic 606, Revenue from Contracts from Customers. The share-based payments are to be measured at grant-date fair value of the equity instruments that the entity is obligated to issue when the goods or service has been delivered or rendered and all other conditions necessary to earn the right to benefit from the equity instruments have been satisfied. This standard will be effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. We adopted the provisions of this ASU on January 1, 2019. The adoption had no impact on our results of operations, cash flows, or financial condition.
Convertible Instruments, Policy [Policy Text Block]	Convertible Instruments The following assumptions were used for the valuation of the derivative liability related to the convertible notes that contain a derivative component during the three months ended September 30, 2020: - The stock prices of $0.0296 to $0.079 in these periods would fluctuate with the Company projected volatility; - The projected volatility curve from an annualized analysis for each valuation period was based on the historical volatility of the Company and the term remaining for each note or warrant ranged from 135.6% through 198.5% at derivative treatment, issuance, conversion, exercise, and quarters ends. The Company continues to trade with high volatility; - The Holder would automatically convert the note at the maximum of 2 times the conversion price if the company was not in default. - The Holder would automatically convert the note before maturity if the registration was effective and the company was not in default. The Holder would automatically convert the note early based on ownership or trading volume limitations and the Company would redeem the unconverted balances at maturity. - A change of control and fundamental transaction would occur initially 0% of the time and increase monthly by 0% to a maximum of 0% – based on management being in control and no desire to sell the Company. - A reset event would adjust the Notes conversion price triggered by either a capital raise; stock issuance; settlement; or conversion/exercise (a reset occurred in this period on 11/7/19 – Auctus Conversion triggered a reset to $0.00858). The reset events are projected to occur annually starting 3 months following the date of valuation 9/30/20. - For the variable rate Notes (39% or 45% discount), the Holder would convert with effective discount rates of 50.28% to 55.17% (based on the lookback terms). - The Company would redeem the notes at maturity if the conversion value was less than the payment with penalties. For the majority of the notes during the period redemption is projected 0% of the time, increasing 0% per month to a maximum of 0%. - The cash flows are discounted to net present values using risk free rates. Discount rates were based on risk free rates in effect based on the remaining term. - An event of default would occur 10% of the time, increasing 0% per month to a maximum of 10%.
Warrants, Policy [Policy Text Block]	Common Stock Purchase Warrants-
Stockholders' Equity, Policy [Policy Text Block]	Stockholders’ Equity-
Earnings Per Share, Policy [Policy Text Block]	Per Share Data- The Company excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are antidilutive for the periods presented. As of September 30, 2020, there were 9,767,879 options and 63,188,385 shares issuable in connection with convertible debt excluded from calculation of diluted net loss; as of September 30, 2019, the Company had outstanding 1,425,000 warrants, 67,879 options, and 36,135,065 shares issuable in connection with convertible debt which were excluded from the calculation of diluted net loss. The Company, at its discretion, may satisfy the accrued interest on its Series A and Series X Preferred Stock via the issuance of shares of common stock; at September 30, 2020 and December 31, 2019, there were 1,731,740 and 0 shares, respectively, potentially issuable in connection with such issuance.
Income Tax, Policy [Policy Text Block]	Income Taxes- Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the condensed consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012.
Business Combinations Policy [Policy Text Block]	Business Combinations- ● future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and ● discount rates utilized in valuation estimates. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the condensed consolidated financial position, statements of operations or cash flows in the period of the change in the estimate.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets-
Fair Value of Financial Instruments, Policy [Policy Text Block]	Financial Instruments and Fair Values- Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable. Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates. Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs and their significance in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the derivative liabilities approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the derivative liabilities as Level 3.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Standards-

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	An Option Pricing Methodology (“OPM”) was utilized to allocate the enterprise value to the various equity linked instruments. The assumptions utilized in the OPM included a term of 5 years as the term for liquidity, a corresponding risk–free rate based on the term, 10% dividends, and a volatility based on the remaining term (based on comparable company volatility analysis): Market Cap (fully diluted basis) 3,749,829 Volatility (12 Months) 78.6 % Years to Liquidity 5.00 Continuous Risk Free Rate 0.88 % Stock Price $ 0.0419

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Convertible Debt [Table Text Block]	Interest Amortization Interest Amortization Expense of Discount Expense of Discount 3 months 3 months 9 months 9 months Discount Principal Balance Accrued Interest ended ended ended ended Balance 9/30/2020 12/31/2019 9/30/2020 12/31/2019 9/30/2020 9/30/2020 9/30/2020 9/30/2020 9/30/2020 Series C Convertible Debenture $ 110,833 $ 110,833 $ 66,029 $ 57,709 $ 2,794 $ - $ 8,320 $ - $ - Series D Convertible Debenture 11,333 11,333 8,047 7,026 343 - 1,021 - - Convertible Note A 41,000 41,000 10,795 7,101 1,240 - 3,694 - - Power Up Note 11 - 45,000 - 1,805 - - 875 38,498 - Power Up Note 12 - 53,000 - 1,499 - - 1,813 46,014 - Power Up Note 13 - 73,000 - 1,488 - - 3,240 66,554 - Eagle Equity Note 1 - 256,000 - 3,367 781 109,019 15,735 248,215 - Eagle Equity Note 2* 50,000 256,000 4,538 1,010 6,166 181,521 21,484 221,800 25,807 Eagle Equity Note 3** 256,000 - 21,041 - 7,743 45,409 21,041 71,312 184,688 Eagle Equity Note 4 129,000 - 8,652 - 3,902 18,083 8,652 33,883 95,117 Eagle Equity Note 5 100,000 - 5,754 - 3,025 11,149 5,754 25,080 78,920 Eagle Equity Note 6 200,200 - 6,057 - 6,057 25,932 6,057 25,932 174,268 Eagle Equity Note 7 200,200 - 2,699 - 2,699 8,123 2,699 8,123 192,077 Eagle Equity Note 8 114,400 - 38 - 38 313 38 313 114,087 PPP Loan 460,406 - 1,879 - 1,160 - 1,879 - - Other - - - 1,865 - - - - - Total $ 1,673,372 $ 846,166 $ 135,529 $ 82,870 $ 35,948 $ 399,549 $ 102,305 $ 785,724 $ 864,964 * Subsequent to September 30, 2020, $50,000 of principal and $4,867 of accrued interest of this note were converted to a total of 3,586,057 shares of the Company’s common stock. As of the date of this filing this note is fully satisfied and there are no further obligations. ** Subsequent to September 30, 2020, $133,000 of principal and $12,146 of accrued interest of this note were converted to a total of 11,170,083 shares of the Company’s common stock.
Schedule of Debt [Table Text Block]	September 30, 2020 December 31, 2019 Total notes payable $ 1,673,372 $ 846,166 Less: Discount (864,964 ) (646,888 ) Notes payable - net of discount $ 808,408 $ 199,278 Current Portion, net of discount $ 808,408 $ 199,278 Long-term portion, net of discount $ - $ -

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	9 Months Ended
	Sep. 30, 2020
Disclosure Text Block [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Derivative liability activity for the year ended December 31, 2019 and the nine months ended September 30, 2020 is summarized in the table below: December 31, 2018 $ - Conversion features issued 1,472,320 Warrants issued 187,968 Settled upon conversion or exercise (689,469 ) Settled upon payment of note (191,827 ) Loss on revaluation 709,431 December 31, 2019 $ 1,488,423 Conversion features issued 1,068,870 Settled upon conversion or exercise (1,020,450 ) Settled upon payment of note (148,949 ) Gain on revaluation (263,042 ) September 30, 2020 $ 1,124,852

Stockholders' (Equity) (Tables)

Stockholders' (Equity) (Tables)	9 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	The following table summarizes the options outstanding at September 30, 2020 and the related prices for the options to purchase shares of the Company’s common stock: Weighted Weighted Weighted average average average exercise exercise Range of Number of remaining price of Number of price of exercise options contractual outstanding options exercisable prices outstanding life (years) options exercisable options $ 0.03 1,250,000 9.67 $ 0.03 250,000 $ 0.03 $ 0.05 7,450,000 9.44 $ 0.05 983,334 $ 0.05 $ 0.06 1,000,000 9.84 $ 0.06 - $ - $ 21.40 67,879 2.41 $ 21.40 67,879 $ 1.16 9,767,879 9.46 $ 0.20 1,301,213 $ 1.16
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Transactions involving stock options are summarized as follows: Shares Weighted- Average Exercise Price ($) Outstanding at December 31, 2018 67,879 $ 21.40 Granted - - Cancelled - - Outstanding at December 31, 2019 67,879 $ 21.40 Granted 11,200,000 $ 0.05 Cancelled (1,500,000 ) 0.05 Outstanding at September 30, 2020 9,767,879 $ 0.20 Exercisable at September 30, 2020 1,301,213 $ 1.16
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The Company valued warrants and stock options during the nine months ended September 30, 2020 and 2019 using the Black-Scholes valuation model utilizing the following variables: September 30, September 30, 2020 2019 Volatility 201.9% to 209.6 % 228.0% to 229.4 % Dividends $ - $ - Risk-free interest rates 0.55% to 1.30 % 1.75% to 2.53 % Term (years) 6.0 to 10.00 5.00
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	The following table summarizes the warrants outstanding at September 30, 2020 and the related prices for the warrants to purchase shares of the Company’s common stock: Shares Weighted- Average Exercise Price ($) Outstanding at December 31, 2018 1,167,653 $ 2.18 Granted 400,000 $ 0.00858 Additional warrants due to trigger of ratchet feature 6,659,382 $ 0.00858 Exercised – cashless conversion (3,514,900 ) $ 0.00858 Forfeited (2,769,482 ) $ 0.00858 Expired (142,653 ) 17.42 Outstanding at December 31, 2019 1,800,000 $ 0.00858 Granted 6,582,382 $ 0.00858 Exercised (8,382,382 ) $ 0.0561 Outstanding at September 30, 2020 - $ -

Description of Business (Detail

Description of Business (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Aug. 27, 2020	Mar. 02, 2020
Description of Business (Details) [Line Items]
Stock Issued During Period, Value, New Issues	$ 71,558
Shares Issued, Price Per Share	$ 14.91	$ 0.034
Series A Preferred Stock [Member]
Description of Business (Details) [Line Items]
Stock Issued During Period, Shares, New Issues	4,800
Shares Issued, Price Per Share			$ 14.91

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - $ / shares	1 Months Ended	3 Months Ended	9 Months Ended		12 Months Ended
	Jan. 31, 2016	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Summary of Significant Accounting Policies (Details) [Line Items]
Share Price (in Dollars per share)		$ 0.0419	$ 0.0419
Fair Value, Change of Control		A change of control and fundamental transaction would occur initially 0% of the time and increase monthly by 0% to a maximum of 0% – based on management being in control and no desire to sell the Company.
Debt Instrument, Convertible, Conversion Price (in Dollars per share)		$ 0.00858	0.00858
Fair Value, Period Redemption		For the majority of the notes during the period redemption is projected 0% of the time, increasing 0% per month to a maximum of 0%.
Fair Value, Events of Default		An event of default would occur 10% of the time, increasing 0% per month to a maximum of 10%
Minimum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Share Price (in Dollars per share)		$ 0.0296	$ 0.0296
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		135.60%	201.90%	228.00%
Note, Discount Rate		39.00%
Maximum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Share Price (in Dollars per share)		$ 0.079	$ 0.079
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		198.50%	209.60%	229.40%
Note, Discount Rate		45.00%
Measurement Input, Discount Rate [Member] | Minimum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Fair Value, Option, Relation to Measurement Inputs		50.28%
Measurement Input, Discount Rate [Member] | Maximum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Fair Value, Option, Relation to Measurement Inputs		55.17%
Share-based Payment Arrangement, Option [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			9,767,879	67,879
Convertible Debt Securities [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			63,188,385	36,135,065
Warrant [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				1,425,000
Share-based Payment Arrangement [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			1,731,740		0
Stockholders' Equity, Reverse Stock Split	1 for 101

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Fair Value Measurement Inputs and Valuation Techniques shares in Millions	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Market Cap (fully diluted basis) (in Shares) | shares	3,749,829
Volatility (12 Months)	78.60%
Years to Liquidity	5 years
Continuous Risk Free Rate	0.88%
Stock Price (in Dollars per share) | $ / shares	$ 0.0419

Financial Condition and Going_2

Financial Condition and Going Concern (Details) - USD ($)	Jul. 21, 2020	May 04, 2020	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and Cash Equivalents, at Carrying Value			$ 101,660	$ 83,245	$ 851	$ 1,304
Liabilities, Current			$ 2,720,646	$ 2,419,285
Proceeds from Notes Payable		$ 460,406
Loan Proceeds that should not have been received	$ 440,000

Related Party Transactions (Det

Related Party Transactions (Details)

Aug. 01, 2020USD ($)$ / sharesshares

Jun. 30, 2020shares

Jun. 01, 2020USD ($)$ / sharesshares

Mar. 02, 2020shares

Feb. 27, 2020USD ($)$ / sharesshares

Aug. 10, 2019USD ($)shares

Jul. 29, 2019USD ($)shares

Mar. 11, 2019USD ($)shares

Sep. 30, 2020USD ($)

Sep. 30, 2019USD ($)

Sep. 30, 2020USD ($)$ / shares

Sep. 30, 2019USD ($)

Dec. 31, 2019$ / shares

Related Party Transactions (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares) | shares

2,000,000

Number of Directors

2

Share-based Payment Arrangement, Expense

$ 78,324

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) | $ / shares

$ 0.05

$ 0.05

$ 0

Share-based Payment Arrangement, Noncash Expense

$ 259,307

$ 154,558

Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares) | shares

250,000

Shares Issued, Shares, Share-based Payment Arrangement, Forfeited (in Shares) | shares

750,000

Dividends, Preferred Stock

$ 19,392

$ 0

56,143

0

Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture

12,230

12,230

Due to Related Parties, Current

2,875

2,875

Share-based Payment Arrangement, Option [Member]

Related Party Transactions (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares) | shares

1,500,000

Share-based Payment Arrangement, Expense

$ 58,743

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) | $ / shares

$ 0.05

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Share-based Payment Arrangement, Noncash Expense

$ 39,432

Restricted Stock [Member]

Related Party Transactions (Details) [Line Items]

Share-based Payment Arrangement, Noncash Expense

69,342

Issued to Each Related Party [Member]

Related Party Transactions (Details) [Line Items]

Share-based Payment Arrangement, Expense

$ 39,162

Issued to Each Related Party [Member] | Share-based Payment Arrangement, Option [Member]

Related Party Transactions (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares) | shares

4,500,000

Share-based Payment Arrangement, Expense

176,229

Share-based Payment Arrangement, Noncash Expense

78,864

Director #2 [Member]

Related Party Transactions (Details) [Line Items]

Share-based Payment Arrangement, Noncash Expense

28,325

Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares) | shares

775,000

Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture

$ 46,500

Director #2 [Member] | Share-based Payment Arrangement, Option [Member]

Related Party Transactions (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares) | shares

1,000,000

Share-based Payment Arrangement, Expense

$ 28,460

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) | $ / shares

$ 0.03

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Share-based Payment Arrangement, Noncash Expense

9,487

Director [Member]

Related Party Transactions (Details) [Line Items]

Share-based Payment Arrangement, Noncash Expense

37,054

Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares) | shares

1,000,000

300,000

100,000

Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture

$ 60,000

$ 3,000

$ 8,740

Director [Member] | Share-based Payment Arrangement, Option [Member]

Related Party Transactions (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares) | shares

1,000,000

Share-based Payment Arrangement, Expense

$ 56,037

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) | $ / shares

$ 0.05

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

10 years

Share-based Payment Arrangement, Noncash Expense

11,595

Management [Member] | Restricted Stock [Member]

Related Party Transactions (Details) [Line Items]

Share-based Payment Arrangement, Noncash Expense

27,196

Employee [Member] | Restricted Stock [Member]

Related Party Transactions (Details) [Line Items]

Share-based Payment Arrangement, Noncash Expense

15,635

President [Member]

Related Party Transactions (Details) [Line Items]

Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares) | shares

100,000

Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture

$ 8,740

Director #3 [Member]

Related Party Transactions (Details) [Line Items]

Share-based Payment Arrangement, Noncash Expense

12,000

Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares) | shares

200,000

Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture

$ 12,000

Investor [Member]

Related Party Transactions (Details) [Line Items]

Accounts Payable, Related Parties

169,355

169,355

Related Party [Member] | Accounts Payable [Member]

Related Party Transactions (Details) [Line Items]

Notes Payable, Related Parties

58,000

58,000

Related Party [Member] | ConsultingServices Note [Member]

Related Party Transactions (Details) [Line Items]

Notes Payable, Related Parties

65,000

65,000

Board Member [Member]

Related Party Transactions (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares) | shares

1,000,000

Share-based Payment Arrangement, Expense

12,876

Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares) | shares

1,000,000

Board Member [Member] | Restricted Stock [Member]

Related Party Transactions (Details) [Line Items]

Share-based Payment Arrangement, Noncash Expense

26,511

Related Party [Member] | Accounts Payable [Member]

Related Party Transactions (Details) [Line Items]

Notes Payable, Related Parties

$ 75,000

$ 75,000

Series X Preferred Stock [Member]

Related Party Transactions (Details) [Line Items]

Dividends, Preferred Stock

49,176

Dividends Payable

15,983

15,983

Series X Preferred Stock [Member] | Officer [Member]

Related Party Transactions (Details) [Line Items]

Dividends Payable

9,750

9,750

Series X Preferred Stock [Member] | Shareholder [Member]

Related Party Transactions (Details) [Line Items]

Dividends Payable

$ 23,443

$ 23,443

Debt (Details)

Debt (Details) - USD ($)		Nov. 11, 2020	Oct. 29, 2020	Oct. 15, 2020	Oct. 06, 2020	Sep. 30, 2020		Sep. 25, 2020	Sep. 09, 2020	Sep. 01, 2020	Aug. 20, 2020	Jul. 30, 2020	Jul. 21, 2020	Jul. 17, 2020	Jul. 09, 2020	Jul. 01, 2020	Jun. 26, 2020	Jun. 23, 2020	Jun. 17, 2020	Jun. 05, 2020	Apr. 08, 2020	Mar. 10, 2020	Jan. 24, 2020	Dec. 19, 2019	Nov. 22, 2019	Nov. 11, 2019	Oct. 07, 2019	Sep. 12, 2019	Aug. 13, 2018	Aug. 10, 2017	Sep. 19, 2016	Mar. 18, 2016	Oct. 31, 2020	Apr. 30, 2018	Nov. 30, 2014	Sep. 30, 2020		Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2020		Dec. 31, 2019		Nov. 05, 2020	Mar. 18, 2018	Nov. 30, 2017	Aug. 31, 2014
Series C Debenture [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																																															$ 100,000
Convertible Debt						$ 110,833																														$ 110,833				$ 110,833		$ 110,833					$ 110,833
Debt Instrument, Interest Rate, Stated Percentage																																															10.00%
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																																															$ 20.20
Debt Instrument, Unamortized Discount						0																														0				0
Amortization of Debt Discount (Premium)																																				0				0
Interest Expense, Debt																																				2,794				8,320
Interest Payable						66,029																														66,029				66,029		57,709
Series D Debenture [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																																														$ 10,000
Convertible Debt						11,333																														11,333				11,333		11,333				$ 11,333
Debt Instrument, Interest Rate, Stated Percentage																																														12.00%
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																																														$ 16.67
Class of Warrant or Rights, Granted (in Shares)																																			495
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																																			$ 20.20
Debt Instrument, Unamortized Discount						0																														0				0
Amortization of Debt Discount (Premium)																																				0				0
Interest Expense, Debt																																				343				1,021
Interest Payable						8,047																														8,047				8,047		7,026
Convertible Note A [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																																													$ 60,000
Convertible Debt						41,000																														41,000				41,000		41,000
Debt Instrument, Interest Rate, Stated Percentage																																													12.00%
Debt Instrument, Convertible, Terms of Conversion Feature																																Pursuant to the terms of the Convertible Note A, the Company is obligated to pay monthly installments of not less than $1,000 the first of each month commencing the month following the execution of the Convertible Note A until its maturity on September 16, 2016 at which time the Company was obligated to repay the full principal amount of the Convertible Note A. The Convertible Note A is convertible by the holder at any time into shares of the Company’s common stock at price of $1.00 per share, and throughout the duration of the note, the holder has the right to participate in any financing the Company may engage in upon the same terms and conditions as all other investors.
Debt Instrument, Unamortized Discount						0																										$ 18,750				0				0
Debt Instrument, Convertible, Beneficial Conversion Feature																																$ 9,375
Stock Issued During Period, Shares, New Issues (in Shares)																													75,000		15,000	15,000		75,000
Shares Issued, Price Per Share (in Dollars per share)																															$ 0.30
Stock Issued During Period, Value, New Issues																													$ 6,750		$ 4,050			$ 7,500
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																														25,000
Debt Conversion, Converted Instrument, Amount																														$ 3,750
Debt Conversion, Original Debt, Amount																														$ 7,860												15,000
Gain (Loss) on Extinguishment of Debt																																										(13,867)
Repayments of Convertible Debt																																										4,000
Amortization of Debt Discount (Premium)																																				0				0
Interest Expense, Debt																																				1,240				3,694
Interest Payable						10,795																														10,795				10,795		$ 7,101
Convertible Note A [Member] | Accrued Interest [Member]
Debt (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																										120,000
Power Up Note 11 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																												$ 45,000
Convertible Debt						0																														0				0		$ 45,000
Debt Instrument, Interest Rate, Stated Percentage																												12.00%
Debt Instrument, Unamortized Discount						0																						$ 3,000								0				0
Repayments of Convertible Debt																																								74,195
Debt Instrument, Payment Terms																												If the Company prepays the Power Up Note 11 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 115%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 11, then such redemption premium is 120%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 125%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 130%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 135%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Power Up Note 11, there shall be no further right of prepayment.
Amortization of Debt Discount (Premium)																																				0				38,498		3,000
Debt Instrument, Increase, Accrued Interest																																										1,642
Interest Expense, Debt																																				0				875
Embedded Derivative, Gain on Embedded Derivative																																								35,420
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity																																								21,266
Interest Payable						0																														0				0		1,805
Power Up Note 11 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Debt Instrument, Convertible, Beneficial Conversion Feature																																										47,187
Amortization of Debt Discount (Premium)																																										45,000
Interest Expense, Debt																																										2,187
Power Up Note 11 [Member] | Minimum [Member]
Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																												$ 0.00006
Power Up Note 12 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																											$ 53,000
Convertible Debt						0																														0				0		53,000
Debt Instrument, Interest Rate, Stated Percentage																											12.00%
Debt Instrument, Unamortized Discount						0																					$ 3,000									0				0
Gain (Loss) on Extinguishment of Debt																																				4,247
Debt Instrument, Payment Terms																											If the Company prepays the Power Up Note 12 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 115%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 12, then such redemption premium is 120%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 125%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 130%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 135%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Power Up Note 12, there shall be no further right of prepayment.
Amortization of Debt Discount (Premium)																																				0				46,014
Debt Instrument, Increase, Accrued Interest																											$ 1,499
Interest Expense, Debt																																				0				1,813
Repayments of Notes Payable																																				84,231
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature																																				(62,569)
Interest Payable						0																														0				0		1,499
Power Up Note 12 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Debt Instrument, Unamortized Discount																																										53,000
Debt Instrument, Convertible, Beneficial Conversion Feature																																										54,969
Amortization of Debt Discount (Premium)																																										6,502
Interest Expense, Debt																																										2,187
Power Up Note 12 [Member] | Accrued Interest [Member]
Debt (Details) [Line Items]
Repayments of Notes Payable																																				3,312
Power Up Note 12 [Member] | Principal [Member]
Debt (Details) [Line Items]
Repayments of Notes Payable																																				53,000
Power Up Note 12 [Member] | Prepayment Penalty [Member]
Debt (Details) [Line Items]
Repayments of Notes Payable																																				27,919
Power Up Note 13 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																										$ 73,000
Convertible Debt						0																														0				0		73,000
Debt Instrument, Interest Rate, Stated Percentage																										12.00%
Debt Instrument, Convertible, Terms of Conversion Feature																										Under the Power Up Note 13, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 13 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 12, at a price equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price shall mean 55% of lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 13 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock
Debt Instrument, Unamortized Discount						0																				$ 3,000										0				0
Gain (Loss) on Extinguishment of Debt																																				4,882
Debt Instrument, Payment Terms																										If the Company prepays the Power Up Note 13 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 115%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 13, then such redemption premium is 120%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 125%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 130%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 135%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Power Up Note 13, there shall be no further right of prepayment.
Amortization of Debt Discount (Premium)																																				0				66,554
Interest Expense, Debt																																				0				3,240
Repayments of Notes Payable																																				115,980
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature																																				86,380
Interest Payable						0																														0				0		1,488
Power Up Note 13 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Debt Instrument, Unamortized Discount																																										73,000
Debt Instrument, Convertible, Beneficial Conversion Feature																																										73,529
Amortization of Debt Discount (Premium)																																										6,091
Interest Expense, Debt																																										529
Eagle Equities Note 1 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																									$ 256,000
Convertible Debt						0																														0				0		256,000
Debt Instrument, Interest Rate, Stated Percentage																									12.00%
Debt Instrument, Convertible, Conversion Price (in Dollars per share)												$ 0.021		$ 0.01572	$ 0.01518		$ 0.01362	$ 0.0132	$ 0.0132	$ 0.0132
Debt Instrument, Convertible, Terms of Conversion Feature																						Under the Eagle Equities Note 1, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 1 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 1, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 1 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Unamortized Discount						0																			$ 6,000											0				0
Debt Conversion, Converted Instrument, Shares Issued (in Shares)												2,320,000		3,429,814	3,188,735		2,045,130	3,243,434	2,023,358	2,015,783
Amortization of Debt Discount (Premium)																																				109,019				248,215
Debt Instrument, Increase, Accrued Interest																																										3,367
Interest Expense, Debt																																				781				15,735
Debt Conversion, Description																									If the Company prepays the Eagle Equities Note 1 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 1, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 1, there shall be no further right of prepayment.
Interest Payable						0																														0				0		3,367
Eagle Equities Note 1 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Debt Instrument, Unamortized Discount																																										256,000
Debt Instrument, Convertible, Beneficial Conversion Feature																																										271,694
Amortization of Debt Discount (Premium)																																										7,784
Interest Expense, Debt																																										15,694
Eagle Equities Note 1 [Member] | Accrued Interest [Member]
Debt (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)															3,188,735
Debt Conversion, Original Debt, Amount												$ 3,720		$ 3,917	$ 3,405		$ 1,855	$ 2,813	$ 1,708	$ 1,608
Eagle Equities Note 1 [Member] | Principal [Member]
Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount												$ 45,000		$ 50,000	$ 45,000		$ 26,000	$ 40,000	$ 25,000	$ 25,000
Eagle Equities Note 2 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																								$ 256,000
Convertible Debt	[1]					50,000																														50,000				50,000		256,000
Debt Instrument, Interest Rate, Stated Percentage																								12.00%
Debt Instrument, Convertible, Conversion Price (in Dollars per share)								$ 0.0153	$ 0.0153	$ 0.01806	$ 0.01896
Debt Instrument, Convertible, Terms of Conversion Feature																								Under the Eagle Equities Note 2, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 2 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 2, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 2 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Unamortized Discount						25,807	[1]																	$ 6,000												25,807	[1]			25,807	[1]
Debt Instrument, Convertible, Beneficial Conversion Feature																								$ 277,476
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								3,574,074	3,556,645	3,005,721	3,194,796
Debt Instrument, Payment Terms																								30 days
Amortization of Debt Discount (Premium)	[1]																																			181,521				221,800
Interest Expense, Debt	[1]																																			6,166				21,484
Debt Conversion, Description																								If the Company prepays the Eagle Equities Note 2 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 2, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 2, there shall be no further right of prepayment.
Interest Payable						4,538	[1]																	$ 1,094												4,538	[1]			4,538	[1]	1,010	[1]
Eagle Equities Note 2 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Amortization of Debt Discount (Premium)																																								8,393		256,000
Interest Expense, Debt																																								2,909		21,476
Eagle Equities Note 2 [Member] | Accrued Interest [Member]
Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 4,683	$ 4,417	$ 4,283	$ 4,573
Eagle Equities Note 2 [Member] | Principal [Member]
Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 50,000	$ 50,000	$ 50,000	56,000
Eagle Equities Note 3 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																							$ 256,000
Convertible Debt	[2]					256,000																														256,000				256,000		0
Debt Instrument, Interest Rate, Stated Percentage																							12.00%
Debt Instrument, Convertible, Terms of Conversion Feature																							Under the Eagle Equities Note 3, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 3 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 3, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 3 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Unamortized Discount						184,688	[2]																$ 6,000													184,688	[2]			184,688	[2]
Debt Instrument, Payment Terms																							30 days
Amortization of Debt Discount (Premium)	[2]																																			45,409				71,312
Interest Expense, Debt	[2]																																			7,743				21,041
Debt Conversion, Description																							If the Company prepays the Eagle Equities Note 3 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 3, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 3, there shall be no further right of prepayment.
Interest Payable	[2]					21,041																														21,041				21,041		0
Eagle Equities Note 3 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Debt Instrument, Convertible, Beneficial Conversion Feature																																							$ 272,412
Amortization of Debt Discount (Premium)																																								250,000
Interest Expense, Debt																																								22,412
Eagle Equities Note 4 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																						$ 129,000
Convertible Debt						129,000																														129,000				129,000		0		$ 156,000
Debt Instrument, Interest Rate, Stated Percentage																						12.00%
Debt Instrument, Convertible, Terms of Conversion Feature																						Under the Eagle Equities Note 4, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 4 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 4, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 4 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Unamortized Discount						95,117																$ 4,000														95,117				95,117
Debt Instrument, Convertible, Beneficial Conversion Feature																						$ 139,021
Debt Instrument, Payment Terms																						30 days
Amortization of Debt Discount (Premium)																																				18,083				33,883
Interest Expense, Debt																																				3,902				8,652
Debt Conversion, Description																						If the Company prepays the Eagle Equities Note 4 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 4, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 4, there shall be no further right of prepayment.
Interest Payable						8,652																														8,652				8,652		0		$ 14,643
Amortization of Debt Issuance Costs and Discounts																																								125,000
Eagle Equities Note 4 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Interest Expense, Debt																																								14,021
Eagle Equities Note 5 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																					$ 100,000
Convertible Debt						100,000																														100,000				100,000		0
Debt Instrument, Interest Rate, Stated Percentage																					12.00%
Debt Instrument, Convertible, Terms of Conversion Feature																					Under the Eagle Equities Note 5, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 5 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 5, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 5 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Unamortized Discount						78,920															$ 4,000															78,920				78,920
Amortization of Debt Discount (Premium)																																				11,149				25,080
Interest Expense, Debt																																				3,025				5,754
Interest Payable						5,754																														5,754				5,754		0
Eagle Equities Note 5 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Debt Instrument, Unamortized Discount																																						$ 100,000
Debt Instrument, Convertible, Beneficial Conversion Feature																																						$ 106,576
Interest Expense, Debt																																								6,576
Eagle Equities Note 6 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount																$ 200,200
Convertible Debt						200,200																														200,200				200,200		0
Debt Instrument, Interest Rate, Stated Percentage																12.00%
Debt Instrument, Convertible, Terms of Conversion Feature																Under the Eagle Equities Note 6, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 6 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 6, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 6 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Unamortized Discount						174,268										$ 18,200																				174,268				174,268
Debt Instrument, Convertible, Beneficial Conversion Feature																$ 218,148
Debt Instrument, Payment Terms																If the Company prepays the Eagle Equities Note 6 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 6, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 6, there shall be no further right of prepayment.
Amortization of Debt Discount (Premium)																																				25,932				25,932
Interest Expense, Debt																																				6,057				6,057
Interest Payable						6,057																														6,057				6,057		0
Amortization of Debt Issuance Costs and Discounts																																								200,200
Debt Issuance Costs, Net																$ 7,000
Interest Expense, Other																																								17,948
Eagle Equities Note 7 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount											$ 200,200
Convertible Debt						200,200																														200,200				200,200		0
Debt Instrument, Interest Rate, Stated Percentage											12.00%
Debt Instrument, Convertible, Terms of Conversion Feature											Under the Eagle Equities Note 7, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 7 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 7, at a price equal to 70% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 7 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Unamortized Discount						192,077					$ 18,200																									192,077				192,077
Debt Instrument, Payment Terms											If the Company prepays the Eagle Equities Note 7 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 7, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 7, there shall be no further right of prepayment.
Amortization of Debt Discount (Premium)																																				8,123				8,123
Interest Expense, Debt																																				2,699				2,699
Interest Payable						2,699																														2,699				2,699		0
Debt Issuance Costs, Net											$ 7,000
Eagle Equities Note 7 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Debt Instrument, Convertible, Beneficial Conversion Feature											$ 15,203
Eagle Equities Note 8 [Member]
Debt (Details) [Line Items]
Debt Instrument, Face Amount						114,400																														114,400				114,400
Convertible Debt						$ 114,400																														$ 114,400				$ 114,400		0
Debt Instrument, Interest Rate, Stated Percentage						12.00%																														12.00%				12.00%
Debt Instrument, Convertible, Terms of Conversion Feature						Under the Eagle Equities Note 8, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 8 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 8, at a price equal to 70% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 8 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Unamortized Discount						$ 114,087																														$ 114,087				$ 114,087
Debt Instrument, Payment Terms						If the Company prepays the Eagle Equities Note 8 during the 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Eagle Equities Note 8, then such redemption premium is 116%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 122%; and if such prepayment is made from the 91st to the 120th day after issuance, then such redemption premium is 128%; and if such prepayment is made from the 121st to the 150th day after issuance, then such redemption premium is 134%; and if such prepayment is made from the 151st to the 180th day after issuance, then such redemption premium is 140%. After the 180th day following the issuance of the Eagle Equities Note 8, there shall be no further right of prepayment.
Amortization of Debt Discount (Premium)																																				313				313
Interest Expense, Debt																																				38				38
Interest Payable						$ 38																														38				38		0
Debt Instrument, Unamortized Discount (Premium), Net						10,400																														10,400				10,400
Eagle Equities Note 8 [Member] | Embedded Derivative Financial Instruments [Member]
Debt (Details) [Line Items]
Debt Instrument, Unamortized Discount						114,400																														114,400				114,400
Debt Instrument, Convertible, Beneficial Conversion Feature						117,309
PPP Loan [Member]
Debt (Details) [Line Items]
Convertible Debt						460,406																														460,406				460,406		0
Debt Instrument, Unamortized Discount						0																														0				0
Amortization of Debt Discount (Premium)																																				0				0
Interest Expense, Debt																																				1,160				1,879
Interest Payable						$ 1,879																														1,879				1,879		$ 0
Debt Instrument, Description													Bank of America notified the Company in writing that it should not have received $440,000 of the loan proceeds disbursed under the Note. The Company investigated the terms of the application and discovered its former President had erroneously represented it was refinancing an Economic Injury Disaster Loan when the Company never applied for or received such a loan. Bank of America has requested that the Company return the funds it received back to Bank of America. The Company is currently negotiating a repayment plan with Bank of America.
Principal [Member] | Power Up Note 11 [Member]
Debt (Details) [Line Items]
Repayments of Convertible Debt																																								45,000
Principal [Member] | Power Up Note 13 [Member]
Debt (Details) [Line Items]
Repayments of Notes Payable																																				73,000
Accrued Interest [Member] | Power Up Note 11 [Member]
Debt (Details) [Line Items]
Repayments of Convertible Debt																																								2,680
Accrued Interest [Member] | Power Up Note 13 [Member]
Debt (Details) [Line Items]
Repayments of Notes Payable																																				4,728
Prepayment Penalty [Member] | Power Up Note 11 [Member]
Debt (Details) [Line Items]
Repayments of Convertible Debt																																								$ 23,815
Prepayment Penalty [Member] | Power Up Note 13 [Member]
Debt (Details) [Line Items]
Repayments of Notes Payable																																				$ 38,252
Subsequent Event [Member] | Eagle Equities Note 2 [Member]
Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)					$ 0.0153
Debt Conversion, Converted Instrument, Shares Issued (in Shares)					3,586,057																												3,586,057
Debt Conversion, Original Debt, Amount																																	$ 50,000
Subsequent Event [Member] | Eagle Equities Note 2 [Member] | Accrued Interest [Member]
Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount					$ 4,867																												$ 4,867
Subsequent Event [Member] | Eagle Equities Note 2 [Member] | Principal [Member]
Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount					$ 50,000
Subsequent Event [Member] | Eagle Equities Note 3 [Member]
Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)		$ 0.0111	$ 0.0123	$ 0.01566
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		3,259,369	4,439,024	3,471,690																													11,170,083
Debt Conversion, Original Debt, Amount																																	$ 133,000
Subsequent Event [Member] | Eagle Equities Note 3 [Member] | Accrued Interest [Member]
Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount		$ 3,179	$ 4,600	$ 4,367																													$ 12,146
Subsequent Event [Member] | Eagle Equities Note 3 [Member] | Principal [Member]
Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount		$ 33,000	$ 50,000	$ 50,000
[1]	Subsequent to September 30, 2020, $50,000 of principal and $4,867 of accrued interest of this note were converted to a total of 3,586,057 shares of the Company’s common stock. As of the date of this filing this note is fully satisfied and there are no further obligations.
[2]	Subsequent to September 30, 2020, $133,000 of principal and $12,146 of accrued interest of this note were converted to a total of 11,170,083 shares of the Company’s common stock.

Debt (Details) - Convertible De

Debt (Details) - Convertible Debt - USD ($)		3 Months Ended		9 Months Ended			12 Months Ended
		Sep. 30, 2020		Sep. 30, 2020		Sep. 30, 2019	Dec. 31, 2019		Nov. 05, 2020	Aug. 20, 2020	Jul. 01, 2020	Apr. 08, 2020	Mar. 10, 2020	Jan. 24, 2020	Dec. 19, 2019	Nov. 22, 2019	Nov. 11, 2019	Oct. 07, 2019	Sep. 12, 2019	Nov. 30, 2017	Mar. 18, 2016	Aug. 31, 2014
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		$ 1,673,372		$ 1,673,372			$ 846,166
Accrued Interest		135,529		135,529			82,870
Interest Expense		35,948		102,305
Amortization of Discount		399,549		785,724		$ 603,861
Discount Balance		864,964		864,964			646,888
Series C Debenture [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		110,833		110,833			110,833															$ 110,833
Accrued Interest		66,029		66,029			57,709
Interest Expense		2,794		8,320
Amortization of Discount		0		0
Discount Balance		0		0
Series D Debenture [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		11,333		11,333			11,333													$ 11,333
Accrued Interest		8,047		8,047			7,026
Interest Expense		343		1,021
Amortization of Discount		0		0
Discount Balance		0		0
Convertible Note A [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		41,000		41,000			41,000
Accrued Interest		10,795		10,795			7,101
Interest Expense		1,240		3,694
Amortization of Discount		0		0
Discount Balance		0		0																	$ 18,750
Power Up Note 11 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		0		0			45,000
Accrued Interest		0		0			1,805
Interest Expense		0		875
Amortization of Discount		0		38,498			3,000
Discount Balance		0		0															$ 3,000
Power Up Note 12 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		0		0			53,000
Accrued Interest		0		0			1,499
Interest Expense		0		1,813
Amortization of Discount		0		46,014
Discount Balance		0		0														$ 3,000
Power Up Note 13 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		0		0			73,000
Accrued Interest		0		0			1,488
Interest Expense		0		3,240
Amortization of Discount		0		66,554
Discount Balance		0		0													$ 3,000
Eagle Equities Note 1 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		0		0			256,000
Accrued Interest		0		0			3,367
Interest Expense		781		15,735
Amortization of Discount		109,019		248,215
Discount Balance		0		0												$ 6,000
Eagle Equities Note 2 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance	[1]	50,000		50,000			256,000
Accrued Interest		4,538	[1]	4,538	[1]		1,010	[1]							$ 1,094
Interest Expense	[1]	6,166		21,484
Amortization of Discount	[1]	181,521		221,800
Discount Balance		25,807	[1]	25,807	[1]										$ 6,000
Eagle Equities Note 3 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance	[2]	256,000		256,000			0
Accrued Interest	[2]	21,041		21,041			0
Interest Expense	[2]	7,743		21,041
Amortization of Discount	[2]	45,409		71,312
Discount Balance		184,688	[2]	184,688	[2]									$ 6,000
Eagle Equities Note 4 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		129,000		129,000			0		$ 156,000
Accrued Interest		8,652		8,652			0		$ 14,643
Interest Expense		3,902		8,652
Amortization of Discount		18,083		33,883
Discount Balance		95,117		95,117									$ 4,000
Eagle Equities Note 5 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		100,000		100,000			0
Accrued Interest		5,754		5,754			0
Interest Expense		3,025		5,754
Amortization of Discount		11,149		25,080
Discount Balance		78,920		78,920								$ 4,000
Eagle Equities Note 6 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		200,200		200,200			0
Accrued Interest		6,057		6,057			0
Interest Expense		6,057		6,057
Amortization of Discount		25,932		25,932
Discount Balance		174,268		174,268							$ 18,200
Eagle Equities Note 7 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		200,200		200,200			0
Accrued Interest		2,699		2,699			0
Interest Expense		2,699		2,699
Amortization of Discount		8,123		8,123
Discount Balance		192,077		192,077						$ 18,200
Eagle Equities Note 8 [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		114,400		114,400			0
Accrued Interest		38		38			0
Interest Expense		38		38
Amortization of Discount		313		313
Discount Balance		114,087		114,087
PPP Loan [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		460,406		460,406			0
Accrued Interest		1,879		1,879			0
Interest Expense		1,160		1,879
Amortization of Discount		0		0
Discount Balance		0		0
Other [Member]
Debt (Details) - Convertible Debt [Line Items]
Principal Balance		0		0			0
Accrued Interest		0		0			$ 1,865
Interest Expense		0		0
Amortization of Discount		0		0
Discount Balance		$ 0		$ 0
[1]	Subsequent to September 30, 2020, $50,000 of principal and $4,867 of accrued interest of this note were converted to a total of 3,586,057 shares of the Company’s common stock. As of the date of this filing this note is fully satisfied and there are no further obligations.
[2]	Subsequent to September 30, 2020, $133,000 of principal and $12,146 of accrued interest of this note were converted to a total of 11,170,083 shares of the Company’s common stock.

Debt (Details) - Schedule of De

Debt (Details) - Schedule of Debt - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Schedule of Debt [Abstract]
Total notes payable	$ 1,673,372	$ 846,166
Less: Discount	(864,964)	(646,888)
Notes payable - net of discount	808,408	199,278
Current Portion, net of discount	808,408	199,278
Long-term portion, net of discount	$ 0	$ 0

Derivative Liabilities (Details

Derivative Liabilities (Details) - Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance	$ 1,488,423	$ 0
Settled upon conversion or exercise	(1,020,450)	(689,469)
Settled	(148,949)	(191,827)
Loss on revaluation	(263,042)	709,431
Balance	1,124,852	1,488,423
Embedded Derivative Financial Instruments [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative issued	$ 1,068,870	1,472,320
Warrant [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative issued		$ 187,968

Stockholders' (Equity) (Details

Stockholders' (Equity) (Details)	Sep. 25, 2020USD ($)$ / sharesshares	Sep. 09, 2020USD ($)$ / sharesshares	Sep. 01, 2020USD ($)$ / sharesshares	Aug. 27, 2020$ / sharesshares	Aug. 20, 2020USD ($)$ / sharesshares	Jul. 30, 2020USD ($)$ / sharesshares	Jul. 17, 2020USD ($)$ / sharesshares	Jul. 09, 2020USD ($)$ / sharesshares	Jun. 26, 2020USD ($)$ / sharesshares	Jun. 23, 2020USD ($)$ / sharesshares	Jun. 17, 2020USD ($)$ / sharesshares	Jun. 05, 2020USD ($)$ / sharesshares	Mar. 10, 2020	Mar. 02, 2020USD ($)$ / sharesshares	Dec. 19, 2019	Sep. 30, 2020USD ($)$ / sharesshares	Sep. 30, 2019USD ($)shares	Sep. 30, 2020USD ($)$ / sharesshares	Sep. 30, 2019USD ($)shares	Dec. 31, 2019USD ($)$ / sharesshares	Jun. 30, 2020shares	Jun. 30, 2019shares	Dec. 31, 2018shares
Stockholders' (Equity) (Details) [Line Items]
Common Stock, Shares Authorized (in Shares)																500,000,000		500,000,000		500,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ / shares																$ 0.01		$ 0.01		$ 0.01
Common Stock, Shares, Outstanding (in Shares)																121,452,914		121,452,914		81,268,443
Common Stock, Shares, Issued (in Shares)																121,452,914		121,452,914		81,268,443
Other Nonoperating Gains (Losses) | $																$ 6,988	$ 0	$ 6,988	$ 0
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares																$ 0.00858		$ 0.00858
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																			14,394,002
Stock Issued During Period, Value, Issued for Services | $																$ 21,656		$ 29,336	$ 17,480
Share-based Payment Arrangement, Noncash Expense | $																		$ 259,307	$ 154,558
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period																			2875 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)																		11,200,000		0
Number of Investors																		2
Class of Warrants, Exercised (in Shares)																		(8,382,382)		(3,514,900)
Stock Issued During Period, Shares, Other (in Shares)				386,985
Shares Issued, Price Per Share (in Dollars per share) | $ / shares				$ 0.034												$ 14.91		$ 14.91
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares)																			2,975,000
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | $																	12,230		$ 12,230
Number of Transactions																			24
Gain (Loss) on Extinguishment of Debt | $																			$ (161,458)
Common Stock Cancelled, Previously Issued (in Shares)																			700,000
Weighted Average Number of Shares, Contingently Issuable (in Shares)																		9,917,879
Debt Instrument, Convertible, Terms of Conversion Feature																		We are also obligated to issue Common Stock upon conversion of certain promissory notes of approximately $1.3 million, or $1.5 million if held for an extended period of time. Most have a conversion feature that could allow the holder to convert to Common Stock at a 40% discount to the market price.
Preferred Stock, Shares Authorized (in Shares)																100,000,000		100,000,000
Stock Issued During Period, Value, Purchase of Assets | $																		$ 71,558	$ 0
Dividends, Preferred Stock | $																$ 19,392	$ 0	56,143	0
Dividends Payable, Current | $																56,143		56,143		$ 0
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | $																$ 253,582		$ 253,582
Principal [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Conversion, Original Debt, Amount | $																			368.882
Accrued Interest [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Conversion, Original Debt, Amount | $																			26,330
Debt Fees [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Conversion, Original Debt, Amount | $																			$ 1,500
Eagle Equities Note 1 [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares						$ 0.021	$ 0.01572	$ 0.01518	$ 0.01362	$ 0.0132	$ 0.0132	$ 0.0132
Debt Conversion, Converted Instrument, Shares Issued (in Shares)						2,320,000	3,429,814	3,188,735	2,045,130	3,243,434	2,023,358	2,015,783
Debt Instrument, Convertible, Terms of Conversion Feature													Under the Eagle Equities Note 1, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 1 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 1, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 1 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Eagle Equities Note 1 [Member] | Principal [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Conversion, Original Debt, Amount | $						$ 45,000	$ 50,000	$ 45,000	$ 26,000	$ 40,000	$ 25,000	$ 25,000
Eagle Equities Note 1 [Member] | Accrued Interest [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Conversion, Original Debt, Amount | $						$ 3,720	$ 3,917	$ 3,405	$ 1,855	$ 2,813	$ 1,708	$ 1,608
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								3,188,735
Eagle Equities Note 2 [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares	$ 0.0153	$ 0.0153	$ 0.01806		$ 0.01896
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	3,574,074	3,556,645	3,005,721		3,194,796
Debt Instrument, Convertible, Terms of Conversion Feature															Under the Eagle Equities Note 2, Eagle Equities may convert all or a portion of the outstanding principal of the Eagle Equities Note 2 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Eagle Equities Note 2, at a price equal to 60% of lowest traded price during the 20 day trading period ending on the day the conversion notice is received by the Company, provided, however, that Eagle Equities may not convert the Eagle Equities Note 2 to the extent that such conversion would result in beneficial ownership by Eagle Equities and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Eagle Equities Note 2 [Member] | Principal [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Conversion, Original Debt, Amount | $	$ 50,000	$ 50,000	$ 50,000		$ 56,000
Eagle Equities Note 2 [Member] | Accrued Interest [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Conversion, Original Debt, Amount | $	$ 4,683	$ 4,417	$ 4,283		$ 4,573
Common Stock [Member]
Stockholders' (Equity) (Details) [Line Items]
Common Stock, Shares, Outstanding (in Shares)																121,452,914	49,868,462	121,452,914	49,868,462	81,268,443	98,796,144	39,077,529	31,598,236
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)																22,269,785	9,115,933	31,597,490
Stock Issued During Period, Shares, Issued for Services (in Shares)																386,985		586,985	200,000
Stock Issued During Period, Value, Issued for Services | $																$ 3,869		$ 5,869	$ 2,000
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares)																	1,975,000		2,975,000
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | $																	$ 19,750		$ 29,750
Services [Member]
Stockholders' (Equity) (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services (in Shares)																		200,000	200,000
Stock Issued During Period, Value, Issued for Services | $																		$ 7,680	$ 17,480
Cashless Exercise of Warrants [Member]
Stockholders' (Equity) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)																		2,901,440
Other Nonoperating Gains (Losses) | $																		$ (24,894)
Class of Warrants, Exercised (in Shares)																		4,480,938
Additional Shares for Variable Conversion Feature on Warrants [Member]
Stockholders' (Equity) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)																		1,011,967
Officers and Board Members [Member]
Stockholders' (Equity) (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period																		128714 years
Agreement with Investors Regarding Exercise Price of Warrants [Member]
Stockholders' (Equity) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)																		1,000,000
Other Nonoperating Gains (Losses) | $																		$ (77,652)
Class of Warrants, Exercised (in Shares)																		2,769,482
Agreement with Investors Regarding Exercise Price of Warrants [Member] | Cashless Exercise of Warrants [Member]
Stockholders' (Equity) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)																		4,098,556
Other Nonoperating Gains (Losses) | $																		$ 259,947
Settlement of Note Payable [Member]
Stockholders' (Equity) (Details) [Line Items]
Debt Conversion, Original Debt, Amount | $																			$ 74,104
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																			1,401,224
Extinguishment of Debt, Gain (Loss), Net of Tax | $																			$ (26,924)
Restricted Stock [Member]
Stockholders' (Equity) (Details) [Line Items]
Share-based Payment Arrangement, Noncash Expense | $																		69,342
Share-based Payment Arrangement, Option [Member]
Stockholders' (Equity) (Details) [Line Items]
Share-based Payment Arrangement, Noncash Expense | $																		$ 39,432
Share-based Payment Arrangement, Option [Member] | Services [Member]
Stockholders' (Equity) (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)																		2,000,000
Number of Consultants																		4
APIC, Share-based Payment Arrangement, Recognition and Exercise | $																		$ 83,720
Share-based Payment Arrangement, Option [Member] | Each Consultant [Member] | Services [Member]
Stockholders' (Equity) (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)																		500,000
APIC, Share-based Payment Arrangement, Recognition and Exercise | $																		$ 20,930
Series A Preferred Stock [Member]
Stockholders' (Equity) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)																		4,800
Shares Issued, Price Per Share (in Dollars per share) | $ / shares														$ 14.91
Preferred Stock, Shares Authorized (in Shares)																27,324		27,324
Preferred Stock, Shares Issued (in Shares)																4,800		4,800		0
Preferred Stock, Dividend Rate, Percentage																		12.00%
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ / shares																$ 0.01		$ 0.01		$ 0.01
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ / shares																$ 25		$ 25
Stock Issued During Period, Shares, Purchase of Assets (in Shares)														4,800
Stock Issued During Period, Value, Purchase of Assets | $														$ 71,558
Dividends, Preferred Stock | $																		$ 6,967
Dividends Payable, Current | $																$ 6,967		$ 6,967
Preferred Stock, Dividend Payment Terms																		if management determined to pay these dividends in shares of the Company’s common stock, this would result in the issuance of 214,898 shares of common stock based upon the average price of $0.03242 per share for the five day period ended September 30, 2020.
Series X Preferred Stock [Member]
Stockholders' (Equity) (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)																3,000,000		3,000,000
Preferred Stock, Shares Issued (in Shares)																26,227		26,227		26,227
Preferred Stock, Dividend Rate, Percentage																		10.00%
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ / shares																$ 0.01		$ 0.01		$ 0.01
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ / shares																$ 25		$ 25
Dividends, Preferred Stock | $																		$ 49,176
Dividends Payable, Current | $																$ 49,176		$ 49,176
Preferred Stock, Dividend Payment Terms																		if management determined to pay these dividends in shares of the Company’s common stock, this would result in the issuance of 1,516,841 shares of common stock based upon the average price of $0.03242 per share for the five day period ended September 30, 2020.
Series X Preferred Stock [Member] | Common Stock [Member]
Stockholders' (Equity) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)																			14,394,002

Stockholders' (Equity) (Detai_2

Stockholders' (Equity) (Details) - Share-based Payment Arrangement, Option, Exercise Price Range - $ / shares	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Dec. 30, 2018
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of options outstanding (in Shares)	9,767,879	67,879	67,879
Weighted average remaining contractual life	9 years 167 days
Weighted average exercise price of outstanding options	$ 0.20	$ 21.40	$ 21.40
Number of options exercisable (in Shares)	1,301,213
Weighted average exercise price of exercisable options	$ 1.16
Option Exercise Price $0.03 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.03
Number of options outstanding (in Shares)	1,250,000
Weighted average remaining contractual life	9 years 244 days
Weighted average exercise price of outstanding options	$ 0.03
Number of options exercisable (in Shares)	250,000
Weighted average exercise price of exercisable options	$ 0.03
Option Exercise $0.05 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.05
Number of options outstanding (in Shares)	7,450,000
Weighted average remaining contractual life	9 years 160 days
Weighted average exercise price of outstanding options	$ 0.05
Number of options exercisable (in Shares)	983,334
Weighted average exercise price of exercisable options	$ 0.05
Option Exercise $0.06 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.06
Number of options outstanding (in Shares)	1,000,000
Weighted average remaining contractual life	9 years 306 days
Weighted average exercise price of outstanding options	$ 0.06
Number of options exercisable (in Shares)	0
Weighted average exercise price of exercisable options	$ 0
Option Exercise $21.40 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 21.40
Number of options outstanding (in Shares)	67,879
Weighted average remaining contractual life	2 years 149 days
Weighted average exercise price of outstanding options	$ 21.40
Number of options exercisable (in Shares)	67,879
Weighted average exercise price of exercisable options	$ 1.16

Stockholders' (Equity) (Detai_3

Stockholders' (Equity) (Details) - Share-based Payment Arrangement, Option, Activity - $ / shares	Feb. 27, 2020	Sep. 30, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Option, Activity [Abstract]
Outstanding,Shares		67,879
Outstanding,Weighted- Average Exercise Price		$ 21.40
Exercisable, Shares		1,301,213
Exercisable, Weighted- Average Exercise Price		$ 1.16
Granted, Shares		11,200,000	0
Granted, Weighted- Average Exercise Price	$ 0.05	$ 0.05	$ 0
Cancelled, Shares		(1,500,000)	0
Cancelled, Weighted- Average Exercise Price		$ 0.05	$ 0
Outstanding,Shares		9,767,879	67,879
Outstanding,Weighted- Average Exercise Price		$ 0.20	$ 21.40

Stockholders' (Equity) (Detai_4

Stockholders' (Equity) (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019
Stockholders' (Equity) (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Line Items]
Dividends		0.00%	0.00%
Term (years)			5 years
Minimum [Member]
Stockholders' (Equity) (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Line Items]
Volatility	135.60%	201.90%	228.00%
Risk-free interest rates		0.55%	1.75%
Term (years)		6 years
Maximum [Member]
Stockholders' (Equity) (Details) - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Line Items]
Volatility	198.50%	209.60%	229.40%
Risk-free interest rates		1.30%	2.53%
Term (years)		10 years

Stockholders' (Equity) (Detai_5

Stockholders' (Equity) (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares	Dec. 31, 2018	Sep. 30, 2020	Dec. 31, 2019
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract]
Outstanding, Shares	1,167,653	1,800,000
Outstanding, Weighted- Average Exercise Price	$ 2.18	$ 0	$ 0.00858
Granted, Shares		6,582,382	400,000
Granted, Weighted- Average Exercise Price		$ 0.00858	$ 0.00858
Additional warrants due to trigger of ratchet feature, Shares			6,659,382
Additional warrants due to trigger of ratchet feature			$ 0.00858
Exercised, Shares		(8,382,382)	(3,514,900)
Exercised, Weighted- Average Exercise Price		$ 0.0561	$ 0.00858
Forfeited, Shares			(2,769,482)
Forfeited, Weighted- Average Exercise Price			$ 0.00858
Expired, Shares			(142,653)
Expired, Weighted- Average Exercise Price			$ 17.42
Outstanding, Shares		0	1,800,000

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member]	Nov. 11, 2020USD ($)$ / sharesshares	Oct. 29, 2020USD ($)$ / sharesshares	Oct. 19, 2020USD ($)ft²	Oct. 15, 2020USD ($)$ / sharesshares	Oct. 06, 2020USD ($)$ / sharesshares	Oct. 31, 2020USD ($)shares
Subsequent Events (Details) [Line Items]
Area of Real Estate Property (in Square Feet) | ft²			3,038
Lessee, Operating Lease, Term of Contract			90 months
Months 1 to 24 [Member]
Subsequent Events (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals			$ 5,317
Months 25 to 36 [Member]
Subsequent Events (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals			5,443
Months 37 to 48 [Member]
Subsequent Events (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals			5,570
Months 49 to 60 [Member]
Subsequent Events (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals			5,696
Months 61 to 72 [Member]
Subsequent Events (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals			5,823
Months 73 to 90 [Member]
Subsequent Events (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals			$ 5,949
Eagle Equities Note 9 [Member]
Subsequent Events (Details) [Line Items]
Debt Instrument, Face Amount		$ 114,400
Debt Instrument, Interest Rate, Stated Percentage			12.00%
Debt Instrument, Term			180 days
Eagle Equities Note 2 [Member]
Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares					3,586,057	3,586,057
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares					$ 0.0153
Debt Conversion, Original Debt, Amount						$ 50,000
Eagle Equities Note 2 [Member] | Principal [Member]
Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount					$ 50,000
Eagle Equities Note 2 [Member] | Accrued Interest [Member]
Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount					$ 4,867	$ 4,867
Eagle Equities Note 3 [Member]
Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	3,259,369	4,439,024		3,471,690		11,170,083
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares	$ 0.0111	$ 0.0123		$ 0.01566
Debt Conversion, Original Debt, Amount						$ 133,000
Eagle Equities Note 3 [Member] | Principal [Member]
Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 33,000	$ 50,000		$ 50,000
Eagle Equities Note 3 [Member] | Accrued Interest [Member]
Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 3,179	$ 4,600		$ 4,367		$ 12,146